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ABSTRACT 
 
Staphylococcus epidermidis is the most common causative agent of relapsing and 
persistent hospital-acquired infections associated with indwelling medical devices. 
Since this bacterium belongs to the human skin microbiota, auto- and/or cross-
infections are highly frequent. Moreover, the increased use of medical devices and 
the great ability of S. epidermidis to colonize them and form biofilms has therefore 
raised this otherwise innocuous skin commensal bacterium to a status of major 
opportunistic pathogen. Biofilms are complex three-dimensional structures of 
bacteria encased in a self-protecting matrix. This structure efficiently protects 
bacteria within the biofilm from the host immune system and antimicrobial killing, 
threatening the achievements of modern medicine. In fact, resistance to 
conventional antimicrobials, mainly multidrug resistance, is rising due to their 
increased and sometimes improper use of antibiotics in both healthcare and 
community settings, therefore impairing the patients’ treatment. In S. epidermidis, 
icaADBC–dependent and –independent (proteinaceous) mechanisms can be 
considered in biofilm development. The one dependent on icaADBC is the best 
described and relies on the synthesis of polysaccharide intercellular adhesin (PIA) 
encoded by the icaADCB operon. Aside from PIA, the accumulation-associated 
protein (Aap) and the biofilm-associated protein (Bap) of S. aureus protein (Bhp), 
represent some of the best-characterized biofilm determinants involved in protein-
mediated biofilm mechanism.  
This thesis starts with the description of distinct optimizations of two important 
techniques for biofilm analysis: biofilm quantification and quantification of biofilm 
gene expression. Furthermore, the antimicrobial susceptibilities of clinical S. 
epidermidis isolates collected in a tertiary-care hospital (Hospital de Santo 
António) were described and their carriage of icaA, aap and bhp biofilm-mediating 
genes and subsequent biofilm formation was characterized. The first findings 
revealed very high antimicrobial resistance among S. epidermidis isolates, mainly 
multidrug resistance, in this Portuguese hospital. An association was found 
between mecA and multidrug resistance phenotype. In addition, by analyzing the 
expression of these biofilm-mediating genes, it was observed that icaA is 
predominantly associated with S. epidermidis biofilm development. It was also 
xviii 
 
confirmed that aap is essential in proteinaceous biofilm development, although 
only S. epidermidis harboring the icaA gene had demonstrated the ability to 
develop thicker biofilms with a more complex biofilm organization. Importantly, the 
role of bhp in the biofilm formation remains uncertain. These findings were also 
confirmed by using commensal isolates. Overall, the findings described in this 
thesis allowed to better characterize the interaction and contribution of icaA, aap 
and bhp to the S. epidermidis biofilm formation process, and contributed to 
increase the knowledge on S. epidermidis device-related infections occurring in 
Portugal. 
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SUMÁRIO 
 
Staphylococcus epidermidis é o mais frequente agente causador de infeções 
hospitalares, recorrentes e persistentes, associadas a dispositivos médicos 
implantados. Sendo esta bactéria parte integrante do microbioma da pele 
humana, auto-infeções e/ou infeções cruzadas são bastante frequentes. A 
utilização crescente de dispositivos médicos, associada à excelente capacidade 
de S. epidermidis em os colonizar e formar biofilmes, elevou o estatuto desta 
outrora inócua bactéria, ao de patogénio oportunista. Biofilmes são estruturas 
tridimensionais complexas de bactérias envoltas por uma matriz protetora. Esta 
estrutura protege as bactérias do sistema imunológico do hospedeiro assim como 
da atuação de antibióticos. A resistência aos antibióticos, principalmente a 
multirresistência, tem aumentado devido ao elevado uso, por vezes inapropriado, 
de antibióticos, quer nas unidades prestadoras de cuidados de saúde quer na 
comunidade, complicando assim o tratamento dos doentes. Na espécie S. 
epidermidis são considerados dois tipos de mecanismos que regulam o 
desenvolvimento de biofilmes: dependentes e independentes do operão icaADBC. 
Os dependentes de icaADBC são os mais estudados e dependem da síntese da 
adesina intracelular polissacarídica (PIA, em inglês), codificado pelo operão 
icaADBC. Os mecanismos independentes de PIA estão fortemente associados à 
produção da proteína associada à acumulação (Aap, do inglês accumulation 
associated proteín) e da proteína homóloga a Bap de biofilmes de S. aureus (Bhp, 
do inglês biofilm-associated protein (Bap) of S. aureus protein).  
O trabalho incluído nesta tese inicia com a descrição da otimização efetuada a 
duas técnicas amplamente usadas na análise de biofilmes – as quantificações do 
biofilme e da expressão de genes envolvidos na formação do mesmo –,aplicadas 
também à análise de biofilmes de S. epidermidis. De seguida, foi descrita a 
suscetibilidade de vários isolados clínicos de S. epidermidis, provenientes de 
doentes tratados num hospital terciário (Hospital de Santo António - Centro 
Hospitalar do Porto), aos antibióticos mais comummente usados contra este tipo 
de infeções, assim como determinada a quantidade de biofilme formado por cada 
isolado, procedida pela caracterização genotípica. Estes resultados revelaram 
uma elevada taxa de resistência aos antimicrobianos principalmente 
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multirresistência tendo-se verificado uma associação entre o fenótipo da 
multirresistência e a presença do gene mecA. Posteriormente descreveu-se a 
relação entre a expressão dos genes associados à formação de biofilme e o 
respetivo crescimento do biofilme, tendo-se verificado que o gene icaA está 
diretamente e de forma predominante, ligado ao desenvolvimento do biofilme na 
espécie S. epidermidis. Por outro lado, verificou-se que o gene aap, mas não bhp, 
desempenha um papel relevante no desenvolvimento do biofilme aquando a 
ausência de icaA. Todavia, apenas isolados que possuam ica no seu genoma 
demostraram capacidade para formar biofilmes mais densos e estruturalmente 
mais complexos. Os resultados supramencionados foram consolidados através da 
inclusão de isolados da comunidade neste estudo. De uma forma geral, os 
resultados descritos nesta tese permitem melhor determinar a interação entre os 
genes icaA, aap e bhp e a contribuição individual destes no processo de formação 
de biofilme assim como contribuem para um entendimento mais alargado das 
infeções associadas a biofilmes de S. epidermidis, em Portugal. 
 
1 
 
CHAPTER 1 
 
 
 
 
LITERATURE REVIEW 
This chapter provides the state of the art knowledge on clinical and molecular 
aspects of the pathogenesis of Staphylococcus epidermidis infections related to 
implanted medical devices. Special emphasis was given to some of the most 
important biofilm-mediating genes and their contribution to biofilm development. In 
the last section of this chapter the main objectives of this thesis are described. 
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1.1. Clinical relevance of Staphylococci associated infections 
The progress of the modern medicine due to enhanced medical knowledge and 
treatments led to an extensive use of indwelling medical devices such as central 
venous catheters, prosthetic joints, cardiac pacemakers and mechanical heart 
valves, vascular grafts, artificial lenses, cerebrospinal fluid shunts, amongst others 
1. Healthcare-associated infections (HAIs) or nosocomial infections, are defined as 
infections occurring during a stay in healthcare facilities that were neither present 
nor incubating at the time of hospital admission and only appear in patients 
hospitalized for 48 hours or longer 2. These infections can take a chronic 
persistent course indicating that host innate and acquired immunity do not deal 
effectively with the causative organism(s), compromising the patient’s quality of life 
3. Besides medical complications, these infections increase both morbidity and 
mortality, primarily among immunocompromised and critically ill patients, and also 
elderly people 3, 4. Although, the use of antimicrobial agents has deeply reduced 
morbidity and mortality of patients, antimicrobial resistance increased substantially 
and is now a serious threat to public health 5-7. Importantly, this high rate of 
antimicrobial resistance (mainly multidrug resistance) has a huge impact on 
patient’s outcome due to failed treatments, which increases the hospitalization 
time, morbidity and even deaths 7-9. Furthermore, economic outcomes are also 
associated 8, 9. 
In industrialized countries, HAIs occurs in 5 to 10% of all hospital admissions 
becoming one of the most serious patient safety issues in modern healthcare 5, 7. 
In 2012, the prevalence of HAIs in Portugal was 10.6%, the highest rate among 
European countries 10. According to recent surveys, the annual economic impact 
of HAIs was approximately $9.8 billion, in the United States of America (USA) 6 
and approximately €7 billion, in Europe (EU) 7. Within the EU’s healthcare 
systems, the overall prevalence of patients, with at least one HAI on any given 
day, was 5.7%. The most prevalent infections were respiratory tract infections 
(pneumonia and lower respiratory tract, 19.4% and 4.1%, respectively) that were 
in 33% of the cases, associated with a medical device. Surgical site infections 
(SSIs; 19.6%), urinary tract infections (UTIs; 19.0%), bloodstream infections (BSIs; 
10.7%) and gastro-intestinal infections (7.7%) are also very common. UTIs and 
BSIs were reported as catheter-related in 59.5% and 39.5% of the cases, 
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respectively 7. Portugal follows the same tendency than in the rest of Europe 10. 
Moreover, Portugal shows the highest rate (85.7%) of central vascular catheter 
utilization in Europe and 31.3% was associated with HAIs 7, 10. Central-line 
associated bloodstream infections (CLABSIs; 40%) were the most common in 
USA, followed by catheter-associated urinary tract infections (CAUTIs; 27%), SSIs 
(23%) and ventilator-associated pneumonias (VAPs; 10%) 6. 
 
 
1.2. Clinical significance of coagulase-negative staphylococci  
Previously considered as harmless inhabitants of human flora of the skin and 
mucous membranes with low virulence potential, coagulase-negative 
staphylococci (CoNS) are now acknowledged as important human pathogens 11, 12. 
Despite the commensal trait, this group of gram-positive bacteria is highly 
prevalent in healthcare related infections worldwide, mainly device- or surgery-
associated infection (Table 1.1) 13, 14. Immunocompromised patients, long-term 
hospitalized and those with implanted foreign bodies are at major risk for CoNS 
infections 11, 15. Moreover, evidence that CoNS species act as a reservoir for 
antibiotic resistance genes, may contribute to the evolution of CoNS as pathogens, 
thus increasing the problem of antibiotic resistance in staphylococcal infections 16. 
CoNS isolated from HAIs had an overall frequency of 11.4% and 7.5%, 
respectively in USA and Europe, with higher incidence in bloodstream infection 
episodes 6, 7. According to the 2012 report, in Portugal, the CoNS isolation rate 
was 4.5% increasing up to 32.6% for CLABSIs 10. Similarly to Portugal, prevalence 
rate in CLABSIs was 34.1% and 32.1% in USA and Germany, respectively 13, 14. 
The CLABSIs infection rate was higher in Canada (53%) and lower in Hungry 
(9.7%), during the same period 17, 18. These data highlights the emergence of HAIs 
and indicates CoNS species as major pathogens in CLABSIs-associated morbidity 
worldwide. 
Currently, 16 species of CoNS have been found in specimens of human origin and 
can be grouped according to the novobiocin susceptibility test. Twelve species 
including Staphylococcus epidermidis, Staphylococcus haemolyticus, and 
Staphylococcus hominis are susceptible to the antibiotic novobiocin and the other 
four species (Staphylococcus cohnii, Staphylococcus saprophyticus, 
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Staphylococcus sciuri and Staphylococcus xylosis) are novobiocin-resistant. S. 
epidermidis is by far the most predominant and persistent specie among CoNS 
clinical isolates, representing up to 80% of CoNS isolated from bloodstream 
cultures 15, 19, 20. Importantly, S. epidermidis, the most isolated CoNS pathogen, is 
also, the most abundant commensal of human skin microbiota 21.  
 
Table 1.1: Principal biofilm-associated microorganisms isolated from indwelling medical devices.  
Indwelling medical devices Principal Microorganisms 
Central venous catheter 
Coagulase-negative staphylococci 
Staphylococcus aureus 
Mechanical heart valve 
Coagulase-negative staphylococci 
Staphylococcus aureus 
Urinary catheter 
Escherichia coli 
Candida spp. 
Enterococcus faecalis 
Proteus mirabilis 
Coagulase-negative staphylococci 
Klebsiella pneumoniae 
Artificial hip prothesis 
Coagulase-negative staphylococci 
Enterococcus spp. 
Staphylococcus aureus 
Artificial voice prothesis 
Candida spp. 
Coagulase-negative staphylococci 
Intrauterine device 
Staphylococcus epidermidis 
Staphylococcus aureus 
Enterococcus spp. 
Candida albicans 
(Adapted from Dufour et al. 
22
) 
 
 
1.3. Pathogenesis of S. epidermidis 
Despite de lack of aggressive toxins, S. epidermidis has others specific virulence 
factors (Table 1.2) mainly molecular factors, which make this opportunistic specie a 
successful pathogen. The biofilm-forming capacity is the major determinant of S. 
epidermidis virulence and, as a consequence, S. epidermidis has become of 
importance in the clinical setting 23-25. In fact, S. epidermidis endogenous 
infections tend to be chronic due to bacterial ability to persist for a long time in the 
human body 25-27.  
6 
 
Table 1.2: Virulence factors of S. epidermidis. 
Virulence factor Gene Function 
Initial adhesion 
  
Autolysin adhesion aae Fibrinogen, fibronectin and vitronectin 
Autolysin E atlE 
Binding to polystyrene and vitronectin; Affects surface 
hydrophobicity 
Serine aspartate binding protein sdrF Binding to collagen 
Fibrinogen binding protein (fbe) sdrG Binding to fibrinogen 
Elastin binding protein ebp Binding to elastin 
Extracellular matrix binding protein embp Binds to fibronectin 
Teichoic acids (a) Binds to fibronectin 
Biofilm accumulation 
  
Polysaccharide intercellular adhesin icaADBC Bacterial cell-cell interaction 
Biofilm-homolog S. aureus protein bhp Intercellular adhesion (b) 
Accumulation-associated protein aap 
Bacterial aggregation (requires proteolytic processing for 
activity) (b) 
Extracellular matrix binding protein embp Bacterial aggregation 
Teichoic acids 
 
Component of biofilm matrix 
Immune evasion 
  
Polysaccharide intercellular adhesin icaADBC 
Protects from IgG, AMPs, phagocytes and complement 
attack 
Extracellular matrix binding protein embp Protects from phagocytes 
Resistance to AMPs 
  
Metalloprotease/elastase sepA Involved in AMPs degradation 
AMP sensing system apsRS Senses AMPS and resistance mechanisms 
Toxins 
  
Phenol soluble modulin psmδ Pro-inflammatory cytolysin 
Exoenzymes 
  
Lipases GehC, GehD gehC, gehD Persistence on human skin 
Serine protease sspA Degradation of fibrinogen and complement factor C5 
Cysteine protease sspB Tissue damage 
Legend: (a) Multiple biosynthetic genes; (b) Independent from PIA. (Adapted from Otto et al.
28
) 
 
1.3.1. Biofilm formation 
Biofilms are complex three dimensional structures described as a community of 
adherent microorganisms encased in a self-produced extracellular matrix, with 
protection as the primary function 29-31. The extracellular polymeric substance 
(EPS) matrix consists in a complex mixture of polysaccharides, proteins, teichoic 
acids and extracellular DNA (eDNA) and other macromolecules 30. EPSs are 
highly hydrated (98% water) thereby, preventing desiccation in some natural 
biofilms, and have adhesion propensity 30, 32. Polysaccharides are major 
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components of EPS matrix, in contrast to eDNA which represent a minor fraction 
of S. epidermidis biofilm matrix 30, 33. The EPS matrix plays a structural stabilizing 
role in biofilms, although it provides inherent protection against some antibiotics 34, 
disinfectants 35 and host-defense mechanisms mainly by neutrophil phagocytosis 
29 contributing significantly to S. epidermidis biofilm survival (see sub-sections 1.3.3. 
and 1.4.). It is generally accepted that the mechanisms underlying these protective 
features are several and might be different for antibiotic or host defense 
mechanism. Moreover, biofilms cells show considerable differences regarding 
gene expression profiles and physiology when compared to free-floating (or 
planktonic) bacteria counterparts 29, 30, 33. The altered gene expression in S. 
epidermidis biofilms is characterized by a reduction of basic cell processes (such 
as, cell division, DNA transcription and protein synthesis) which are linked to the 
pathogenesis of S. epidermidis biofilm infection and to the protective mechanisms 
mentioned above 36.  
The dynamic process of biofilm formation comprises three major and successive 
phases: (I) primary attachment of planktonic cells, (II) accumulation into multiple 
bacterial layers and maturation of the biofilm architecture and finally (III) 
detachment and dispersion of planktonic cells, which then may initiate a new cycle 
of biofilm formation elsewhere 29, 30, 33 (Fig. 1.1). All three phases are crucial for 
biofilm-associated infections. 
(I) Primary attachment: The first phase of biofilm formation is characterized by the 
attachment either to biotic surfaces (such as, tissues and/or conditioning films) or 
abiotic (such as, indwelling medical devices) and is mediated by both specific and 
non-specific mechanisms, respectively 29. Indeed, primary attachment is a 
prerequisite for biofilm formation in indwelling medical devices.  
The attachment to abiotic surfaces depends on physicochemical properties of the 
material used and on bacterial cell surface characteristics, and is driven mostly by 
hydrophobic and electrostatic interactions and reversible van der Waals forces 37, 
38. The S. epidermidis major surface-bound autolysin AtlE (148 KDa) is also 
involved in the primary attachment to polystyrene surfaces 39, 40. Of note, AtlE 
protein contains two domains with bacteriolytic activity: an amidase domain (60 
kDa) and a glucosaminidase (52 kDa) domain, but lacks the Leu-Pro-Xaa-Thr-Gly 
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(LPXTG) motif responsible for cell surface linkage and very common in others cell 
wall proteins 40. AtlE, as other autolysins, has enzymatic and adhesive 
characteristics. Moreover, chromosomal DNA release from S. epidermidis 
(extracellular DNA) via the AtlE activity, was also found to be involved in primary 
attachment 41. Two related staphylococcal surface-associated proteins  ̶  Ssp1 
(280 KDa) and Ssp2 (250 KDa; a probable degradation production of Ssp1), were 
previously identify by Veenstra and coworkers, as contributors for this mechanism 
42. Although, recent findings suggested that, those proteins may be related to the 
accumulation-associated protein i.e., Aap 43-45.  
 
 
Figure 1.1: Representation of S. epidermidis biofilm formation and virulent factors involved in each 
phase. Attachment that occurs directly to uncoated surfaces (A) is mainly dependent on cell surface 
hydrophobicity, autolysins and teichoic acids, whereas bacterial attachment to coated surfaces as indwelling 
medical devices (B) is mediated via MSCRAMMs. After adhesion, biofilm accumulation and followed maturation is 
mediated by PIA, surface proteins, eDNA and also teichoic acids. The last phase is the detachment of biofilm cells 
that may leads to the colonization of new infecting sites in human body. (Adapted from Otto, 2009 
28
)  
 
Conversely, the attachment to a conditioning film composed of specific 
extracellular matrix (ECM) proteins (such as, fibrinogen, fibronectin, vitronectin, 
thrombospodin and collagen) and coagulation products (thrombi and activated 
platelets), might represent a more important mechanism of bacterial adherence 
and colonization 46. The surface-associated adhesins designated as microbial 
surface components recognizing adhesive matrix molecules (MSCRAMMs) 
To polymer surface (non-specific):
Autolysins (as, AtlE)
Teichoic acids
Surface hydrophobicity
To host matrix proteins (specific):
MSCRAMMs (as, SdrG/Fbe, Embp,  AtlE)
Adhesive factors:
PIA
eDNA
Surface proteins (Aap, Bhp)
Disruptive factors:
PSMs
Proteases 
Nucleases
Disruptive factors:
PSMs
Proteases
Nucleases
Attachment Accumulation andMaturantion Detachment
A B
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accomplish binding of S. epidermidis to ECM proteins promoting the bacterial 
adherence to host tissues or matrix protein-coated devices 47. The most important 
autolysin/adhesin is AtlE 40. In fact, AtlE has a dual role in attachment as it 
promotes binding to uncoated polystyrene surfaces and to plasma protein-coated 
polymer surfaces 40, 48. Similar to AtlE, the so called autolysin/adhesin from S. 
epidermidis (Aae; 35 KDa) show vitronectin-binding ability and bacteriolytic activity 
49. Other staphylococcal-binding proteins such as the fibrinogen-binding Fbe/SdrG 
(119 KDa) 50-53, the extracellular matrix binding protein (Embp; 1 MDa) 54, 55 and 
the lipase GehD (45 KDa) which promotes the attachment to collagen coated 
surfaces 56, also binds to ECM proteins and mediates adherence of S. epidermidis 
bacterial cells. Both fbe and embp genes were show to be widely distrusted in S. 
epidermidis clinical isolates 50, 57, 58.  
In addition, purified teichoic acids  ̶  a source of polyanionic charge, have been 
shown to be involved in adherence to fibronectin 59. Teichoic acids occur in two 
major forms; the lipoteichoic acids, which are linked to the cell wall, and the wall 
teichoic acids, which are covalently linked to peptidoglycan present in the biofilm 
matrix 60. 
(II) Bacterial accumulation and maturation: This second phase of biofilm formation 
is characterized by the formation of multilayered bacterial clusters on top of the 
monolayer previously formed and followed by bacterial maturation. 
So far, several molecules are responsible for this cell-to-cell adhesion but the 
polysaccharide intercellular adhesin (PIA) is the best studied 61-65. Previously 
referred as capsular polysaccharide/adhesin (PS/A) 66, 67, the PIA molecule also 
known as poly-N-acetylglucosamine (PNAG) 68, is a major functional component of 
the biofilm matrix 61, 63. The chemical structure of PIA was originally determined in 
1996 by Mark and coworkers 62. PIA is a homoglycan of β-1,6-linked N-
acetylglucosamine (GlcNAc) residues and comprises two structurally related 
polysaccharides, a major polysaccharide I (80%) and a minor polysaccharide II 
(20%), with an average chain length of 130 N-acetylglucosamine residues 62. On 
average, 80% of PIA molecule is N-acetylated, while the rest is non-N–acetylated 
and positively charged, which is essential for the functional activity of PIA 62, 69. At 
the molecular point of view, production of PIA is encoded by the intercellular 
adhesin (ica) genetic locus 61, 63. The ica operon (Fig. 1.2) is composed by four 
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open reading frames  ̶  icaA, icaD, icaB, and icaC, and the expression of all four 
icaADBC genes is required for a production of an active PIA molecule 63. IcaR is 
found upstream of the icaA start codon and encodes a 185 amino acid (aa) tetR-
type transcriptional regulator and negatively regulates the icaADBC transcription 
70, 71. IcaA (48 KDa) is an integral transmembrane protein with catalytic activity that 
works in tandem with IcaD (11 KDa) for full in vitro N-acetylglucosaminyl 
transferase activity as demonstrated by Gerke and coworkers 63. Together, icaAD 
synthesized oligomers up to 20 residues of length 61, 63. Moreover, icaD seems to 
act as a link between icaA and icaC genes 63. IcaC (42 KDa) has a putative role in 
the elongation, externalization and translocation of the growing polysaccharide to 
the cell surface and is responsible for the synthesis of the full-length PIA molecule. 
IcaA, IcaC and IcaD are all transmembrane protein but in contrast to IcaA and 
IcaD, IcaC has no transferase activity 61, 63. The expression of icaADC is a 
necessary requirement for the production of PIA. IcaB (34 KDa) is responsible for 
deacetylation of PIA, and crucial for PIA full activity in biofilm formation and 
virulence of S. epidermidis strains 69, 72. In addition to its function in cell-to-cell 
adhesion, PIA is also responsible for the hemagglutinating activity of S. 
epidermidis 73, 74. Of note, DNA sequences homologous to the ica locus were 
detected in a variety of CoNS species (such as, Staphylococcus capitis, 
Staphylococcus cohnii, Staphylococcus saprophyticus, Staphylococcus 
lugdunensis and Staphylococcus intermedius) as well as in Staphylococcus 
aureus 75, 76. Many epidemiological studies have in fact, demonstrated that the 
presence of icaADBC operon is linked to the chronic and persistent nature of S. 
epidermidis biofilm infections 61, 77-80.  
Although PIA synthesis is considered the predominant mechanism of biofilm 
accumulation in the last decade, many S. epidermidis clinical strains lacking the 
ica genes have been isolated at the clinical setting, suggesting the existence of 
additional factors independent from PIA, that could be involved in the 
pathogenesis of S. epidermidis 58, 81-83.  
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Figure 1.2: Representation of S. epidermidis Ica proteins and icaADBC gene. A) The PIA molecule is 
synthesized by the membrane-located GlcNAc transferase IcaA, which needs IcaD membrane protein for activity 
①. The growing polysaccharide chain is exported by the IcaC membrane protein ②, then IcaB removes some of 
the N-acetyl groups, giving the polymer a cationic character that is essential for surface attachment ③. B) The Ica 
proteins are encoded by the ica gene locus containing the icaADBC operon and the icaR gene, which encodes a 
regulatory protein. Expression of the icaADBC operon is regulated either directly at the icaA promoter or through 
expression of IcaR, both of which are controlled by a series of global regulatory proteins (SigB, SarA and LuxS). 
(Adapted from Otto, 2009 
28
) 
 
Meanwhile, the Aap 84, 85 and the homologue to the biofilm-associated protein 
(Bap) of S. aureus protein (Bhp, biofilm-homologous protein) 86 were accomplished 
as mediators in the biofilm formation mechanism acting as proteinaceous 
intercellular adhesins. Aap protein (140 KDa) is anchored via a LPXTG motif and 
comprises two major domains. The domain A may itself contain a lectin-like 
domain and the repetitive domain B, consisting of 128 aa repeats 43, 44, 87. The 
removal of the N-terminal domain A of S. epidermidis Aap protein via proteolytic 
activity leads to exposure of domain B and gives adhesive proprieties to the Aap. 
By this mechanism, Aap is able to promote biofilm accumulation 43, 85, 88. The 
surface protein homologous to the Bap of S. aureus i.e. Bhp 89, was also 
associated with a PIA-independent mechanism of biofilm formation in S. 
epidermidis clinical isolates, even if less frequent than Aap 57, 90, 91. Bhp (239 KDa) 
A
B
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is a protein composed of N-terminal signal sequence follow by three large 
domains: the domain A, domain B (with unknown function) and the domain C. The 
domain C is composed of 16 tandem repeats of 86 amino acids each. The C-
terminal segment contains an LPXTG motif and a wall-membrane-spanning region 
86, 89. Nevertheless, furthers studies are needed to determine the Bhp impact in S. 
epidermidis biofilm development and pathogenesis. The presence of aap is now 
considered as icaADBC operon i.e., an important virulence factor 45, 88, 92, 93. 
Additionally, teichoic acids are not only key contributors to S. epidermidis adhesion 
but also, to colonization and inflammation process (see section 1.4.) playing a major 
contribution into staphylococcal pathogenesis 60, 94, 95. 
(IV) Bacterial detachment and dispersion: It is believed that this last phase is crucial 
to the survival of bacteria, either due to nutrients limitation, or simply to the 
dissemination of S. epidermidis cells (individually or in clusters) that may lead to 
the colonization of additional infecting sites in the human body 96. In general, 
detachment and dispersion occur in response to environmental and growing 
conditions or by a sensu stricto manner 97, 98. Some researchers have also 
suggested that detachment is a self-control mechanism seems to regulate biofilm 
structure and thickening process, in order to achieve a balance 99-101. Indeed, 
detachment is considered a “growth-associated phenomenon” 101. This 
phenomenon is mediated through a combined effect between bacterial quorum 
sensing via agr system (see section 1.3.2.), shear forces and biofilm strength 100-104. 
Notwithstanding, the mechanisms underlying S. epidermidis biofilm detachment 
are still not fully understood. 
 
1.3.2. Regulation of S. epidermidis biofilm formation 
Staphylococcal biofilm formation is under the control of a complex network of 
signaling molecules that regulate either activation or inhibition of the expression of 
specific biofilm components 96, 105. Watnick and his colleague Kolter 106, had 
compared biofilms to cities were microbes are “social organisms” able to 
communicate between then, in a process called quorum sensing (QS). These 
communities produce and secrete signaling molecules (the so called, 
autoinducers) which trigger a cascade of cellular responses regulating gene 
expression in a cell-density-dependent manner and enabling the bacteria to adapt 
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to changing environmental conditions 105, 107. Additionally, autoinducers are 
involved in both intra- and inter-species communication 96, 107, 108. Although more 
studied in S. aureus, the QS was implicated in all phases of biofilm formation and 
directly linked to S. epidermidis pathogenesis 96, 105. Not less important, QS 
significantly impacts the interaction of staphylococci species with innate host 
defense, owing potential as therapeutic targets for control of staphylococcal 
infections 109. In Staphylococci, two main QS systems have been identified and 
characterized: the (I) agr QS system 105, 110-112 and the (II) luxS QS system 113. 
(I) agr QS system: The agr system is composed by RNAII and RNAIII units that are 
respectively regulated by P2 and P3 promoters (Fig. 1.3.). RNAIII includes an open 
reading frame (hld gene) encoding the δ-toxin 105, 114. Of note, it has been 
speculated that S. epidermidis δ-toxin  ̶  a member of the phenol-soluble modulins 
(PSMs) family, may prevent adherence to abiotic surfaces 115, 116. Despite 
surfactant properties, the S. epidermidis δ-toxin is known to cause the lysis of 
erythrocytes by forming pores in the cytoplasmic membrane 117. In S. aureus, the 
RNAIII molecule was found to regulate the expression of many genes encoding 
cell wall-associated proteins via the RNAIII-inhibiting peptide (RIP) 118.  
Moreover, it is accepted that RNAIII is the effector molecule of the accessory gene 
regulation 118, 119. Conversely, RNAII contains a sequence of four co-transcribed 
genes: agrB, agrD, agrC, and agrA 111, 120. The agrACDB operon is organized in a 
two-component transmembrane transduction complex (AgrA and AgrC), a pro-
signalling peptide (AgrD), and a membrane component (AgrB). The AgrA gene 
binds to two promoters and activate via an auto-feedback manner, the 
transcription of the Agr operon. The agrB and agrD gene are responsible for the 
production and externalization of autoinducing peptides (AIP) 105, 120. AgrC detects 
the secreted AIP and activates the regulator protein AgrA which in turn up-
regulates promoters P2 and P3 105, 119. So, AgrA directly activates the expression 
of PSMs, a group of amphipathic peptides with pro-inflammatory properties 
encoded by the hld gene 121-123. PSMs are important in producing mature biofilm 
structures and causing biofilm detachment 36, 124, 125. The production of agr-
regulated proteases and DNAses also has an important effect on staphylococcal 
biofilms development 105, 109. Many studies have pointed out that the agr system 
plays a central role in staphylococcal pathogenesis 105, 109, 115, 126. However, more 
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recent in vivo studies suggest that this role may be subtle 127-130. Among the 
regulation of the expression of toxins (as, δ-toxin), cell surface proteins (as, 
MSCRAMMs) and adhesins (as, AtlE), the agr system also controls the interaction 
with the host immune system (see section 1.4.) 96, 130. In addition, agr QS system is 
also associated to bacterial adaptation to different environmental situations in a 
more general way 131. 
 
Figure 1.3: Representation of S. epidermidis agr QS system. ArgD encodes a peptide, which is processed 
and secreted by AgrB. Mature AIP interact with the histidine sensor kinase AgrA, leading to the phosphorylation of 
the response regulator ArgC, which in turn activates transcription from the two agr promoters. The P2 promoter 
drives the auto-activation circuit, and the P3 promoter drives transcription of the regulatory RNA (RNAIII), which 
is the regulatory effector of the system. (Adapted from Novick and Geisinger 
132
)  
 
(II) luxS QS system: This system uses the LuxS/autoinducer-II (LuxS/AI-II) signal, 
which acts as a “universal signal” mainly in inter-species communication 113, 133. 
Although the most spread QS system, an in vitro study carried by Lin and 
coworkers 134, suggested that luxS gene has no implication in S. epidermidis 
biofilm development. However, luxS has been linked to the decreases of bacterial 
accumulation hence, blocking the production of PIA via down-regulation of 
icaADBC operon 135.  
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Of note, down-regulation of the QS systems might enhance the success of S. 
epidermidis as a pathogen through the increased production of colonization 
factors, biofilm formation and reduced activation of the host immune response 105, 
126. 
 
1.3.3. Antimicrobial resistance 
Another important virulence factor of S. epidermidis is the resistance to 
antimicrobial agents. This bacterial resistance can be either innate (also referred 
as intrinsic resistance) or acquired 35, 136.  
The acquired antimicrobial resistance is closely related to the widely use of 
antimicrobial agents in the clinical practice and especially due to prolonged 
therapy 137, 138. Acquired resistance occurs mainly by gene mutation and horizontal 
transfer of genes or either by combination of both 136, 139. The process of horizontal 
transfer of genes relies on acquisition of exogenous genes via conjugation 
(plasmids and transposons), transformation (incorporation of chromosomal DNA 
released and/or plasmids from other bacteria) and transduction (bacteriophages) 
136, 139. Conjugation is the most common mechanism in horizontal gene transfer 
and acts as a key intervenient in the dissemination of antibiotic resistance mainly 
multidrug resistance 136, 137. As mentioned before, Staphylococci species are 
notorious for evolving and spreading antibiotic resistance mechanisms, impairing 
treatment and patients’ quality of life 35, 137. The most prevalent mechanism of 
acquired resistance identified in Staphylococci with clinical importance is the 
inactivation of β-lactams mainly penicillin antibiotics. Methicillin – a type of 
penicillin antibiotic was for many years, an antibiotic of first choice against 
staphylococci 15, 140. Nowadays, approximately 80% of S. epidermidis clinical 
isolates are resistant to methicillin and not less important, 30 to 40% of community 
isolates obtained from healthy individuals also show to be resistant to methicillin 
140-144. Methicillin-resistance in staphylococci is caused by expression of penicillin-
binding protein 2 (PBP2a) which has low affinity for all β-lactam antibiotics 145. 
PBP2a is a high-molecular weight class B trans-peptidase that catalyzes the 
formation of peptidoglycan and is encoded by the mecA gene that is located on a 
mobile genetic element called the staphylococcal cassette chromosome (SCC) 145, 
146. Maximal expression of resistance by PBP2a requires the efficient and correct 
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synthesis of the peptidoglycan precursor 146. There is evidence of horizontal 
transfer of SCC cassettes between staphylococcal species which implies that 
CoNS could serve as a reservoir for the spread of resistance genes 143, 147. Five 
different types of SCCmec (I to V) have been described by the particular 
combination of two parts: the cassette chromosome recombinase (ccr) gene 
complex and the mec complex 148-150. Only the SCCmec types I, IV and V do not 
contain any antibiotic resistance genes 148. To date, 11 different structural 
elements of SCCmec have been observed in methicillin-resistant S. epidermidis 
(MRSE) 151. In addition, several epidemiological studies have pointed out the high 
prevalence of SCCmec type IV among both clinical and commensal S. epidermidis 
strains worldwide 152-157. 
Despite the importance of S. epidermidis acquired antibiotic resistance the innate 
resistance also plays a crucial role in the widespread of antimicrobial resistance. 
Furthermore, both acquired and innate resistances are closely linked to the 
increased pathogenesis of device-related biofilm infections.  
Often the best treatment to device-related infections, is the removal of the infected 
device, but in the case of joint prothesis implants or biofilm growth on host tissue, 
implants or tissue removal is not always the most appropriate clinical attitude 158. 
In those cases, antimicrobial therapy is the treatment choice. Of concern, sessile 
populations are up to 1000-fold more resistant to antimicrobial agents than 
planktonic counterparts 159. As mentioned earlier, EPS biofilm matrix can act also 
as an active barrier limiting antibiotic diffusion 34, 35. Notwithstanding, in some in 
vitro studies antibiotics such as rifampin, vancomycin, and daptomycin, have been 
shown to penetrate and diffuse easily into the S. epidermidis biofilm matrix 160, 161 
even if some fail to kill sessile bacteria 160. Interestingly, most S. epidermidis 
isolates are still susceptive to those antibiotics. Facing the widespread use of 
antibiotics, resistance has raised and is currently regarded as a major concern 
worldwide (Fig. 1.4.) 6, 7.  
Two others intrinsic mechanisms are also associated to EPS biofilm matrix: the 
presence of specific resistance mechanisms as the deployment of adaptive stress 
responses, and the so called, dormant and persister biofilm cells 162-165. So, while 
some bacteria may activate stress responses, others may differentiate into a 
protected phenotype. Dormancy is characterized as a decrease of basic cell 
metabolic processes such as, DNA replication or protein translation 162. It has 
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been assumed that, cells under a physiological “dormant” state are more prone to 
survive under stress conditions. Moreover, this specific process decreases the 
efficacy of many antibiotics, mainly those that target cell wall activity and protein 
synthesis 35. On the other hand, persister cells are recognized as cells that “neither 
grow nor die” in the presence of antimicrobial agents 162. In fact, persister cells 
showed to be extremely tolerant to high concentrations of antibiotics highlighting 
their contribution to antibiotic resistance 162, 166. Bacterial cells that persist under 
antibiotic treatment tend to repopulate the biofilm thereby, resulting in recalcitrant 
infections 162, 166. While significant, persister cells represent a small portion of the 
biofilm population 162. Both dormant and persister cells, not only prevent bacterial 
death by reducing the efficacy of many antibiotics but also elicit a reduced host 
inflammatory response (see section 1.4.) 36, 167. These distinct phenotypes by 
themselves can confer an intrinsic resistance to some antimicrobial classes, 
including resistance to penicillin, quinilones and glycopeptides 34, 137, 168.  
 
 
Figure 1.4: Timeline of antibiotic deployment and the evolution of antibiotic resistance. (Adapted 
from Clatworthy et al., 2007 
169
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In order to understand the way how resistance develops, it is first important to 
understand how each antimicrobial agent acts. Antimicrobial agents are often 
categorized according to their principal mechanism of action that include inhibition 
of cell wall synthesis and of cell membrane function, inhibition of protein synthesis, 
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interference with nucleic acid synthesis and inhibition of a metabolic pathway 35, 
170. Some of the most important antibiotics with clinical use for treatment of S. 
epidermidis infections are described below. Importantly, evidences about the 
decline interest in antimicrobial drugs discovery by commercial entities are of 
major concern 171, 172. 
Cell membrane and cell wall-active antibiotics 
Most of the glycopeptides-resistant clinical isolates are resistant to teicoplanin, but 
susceptible to vancomycin 173. Vancomycin is a glycopeptide that binds to the 
peptidoglycan side chains in the cell wall, preventing cross-linking during cell wall 
synthesis 174. In fact, the cell wall is the target of this antibiotic. Its effect leads to a 
weakened cell wall, slowing growth and eventually causing death of bacterial cells. 
The efficacy of vancomycin treatment for S. epidermidis biofilm infections has 
been evaluated and susceptibility rates to vancomycin were found to be around 60 
to 100% in clinical isolates 160, 175. Many studies had shown that the treatment of 
biofilms with vancomycin had increase its efficacy if in combination with other 
antibiotics (rifampicin, gentamicin, clindamycin) and also had shown it led to a 
better penetration of the drugs into the biofilm increasing cell death 160, 176, 177. 
Despite some increased resistance, vancomycin remains a treatment of choice for 
invasive staphylococcal infections 178. Moreover, novel antibiotics have been 
developed to overcome the difficult situation of vancomycin, considered the last 
effective antibiotic against many multi-resistant strains 178. 
Daptomycin is a relatively new lipopeptide drug, with proven successful against 
several forms of Gram-positive infections 179-182. This bactericidal agent consists of 
a 13-member amino acid cyclic lipopeptide with a decanoyl side-chain that confers 
a unique mode of action 183, 184. The lipophilic daptomycin tail binds to the bacterial 
membrane, in the presence of physiological levels of calcium ions causing 
disruption of membrane structure 183-185. This is followed by arrest of DNA, RNA 
and protein synthesis resulting in bacterial cell death 183, 184. For treatment of 
biofilm infections, daptomycin alone is more effective than other monotherapies 
used to combat staphylococcal infections 186. Due to mechanism of action, 
daptomycin appears to be an excellent therapeutic option against staphylococcal 
infections 161, 179, 181, 182, 186-188. 
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Inhibitors of DNA and RNA synthesis 
Rifampin or rifampicin is an inhibitor of DNA and RNA synthesis. It targets the 
bacterial RNA polymerase and inhibits RNA synthesis 189. Several in vitro studies, 
it has been observed that rifampicin is surprisingly effective against staphylococci 
biofilm. In S. epidermidis, the antibiotic effectively penetrates the biofilm layers, 
preventing biofilm formation 160, 190, 191. Owing to increased resistance, rifampicin if 
used in the treatment of catheter-related infections must be used in combination 
with other antimicrobials or dispersal agents 192-195. Moreover, due to intrinsic 
mechanisms, S. epidermidis easily become resistant to rifampicin by accumulating 
mutations in the RNA polymerase β subunit (rpoB) gene, which encodes the β 
subunit of bacterial RNA polymerase 35, 196. Currently, resistance has remained at 
a relatively low level but is a significant concern for all staphylococcal infections 7.  
Inhibitors of protein synthesis 
Oxazolidinones are a new group of synthetic drugs that have demonstrated activity 
against in vivo and in vitro bacterial biofilms and also, against methicillin- and 
vancomycin-resistant S. epidermidis strains 197, 198. Oxazolidinones inhibit 
ribosome function and prevent protein synthesis by disrupting assembly of 
ribosomal subunits, owing a unique mechanism distinct from other ribosome-
targeting drugs 197, 199. Linezolid is the first oxazolidinone available and so far, the 
only approved for clinical use 200. 
 
1.4. Host immune response to S. epidermidis 
As previously mentioned, biofilms are a physical result of adaptive features by 
many bacterial species, including S. epidermidis. Notwithstanding, the 
physiological changes in S. epidermidis biofilms that protect the bacteria from 
antimicrobial agents and enable the bacteria to persist during infection, also 
protect from the host immune system by phenotypic shifting to a non-aggressive 
state, reducing inflammation and the chemotaxis of immune cells to the site of 
infection 36, 201, 202. 
The innate immune system is the human body’s first-line of defense against 
invading microorganisms 203. Among other, it includes three important 
mechanisms that enable killing of bacteria: secretion of antimicrobial peptides 
(AMPs) 203, 204 and complement activation followed by neutrophil mediated killing 
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203, 205. Serum complement coats the bacteria and then the opsonized bacteria are 
uptaken by the host “professional” phagocytes 203, 205, 206. The complement system 
can be activated by three pathways that differ in their mode of recognition 205. The 
classical pathway is activated by C1q lectin either by direct recognition of S. 
epidermidis surface structures or by binding to surface-bound antibodies. The 
lectin pathway is activated through binding of mannose-binding lectin to various 
carbohydrate residues. The alternative pathway is activated spontaneously, but 
will only proceed if bacterial surfaces are present. This pathway may also act as 
an efficient amplification loop for both the classical and lectin pathways. All 
pathways converge at C3 205. Furthermore, killing is also achieved by a vast array 
of proteases, lipases and amidases, and by nutrients limitation (such as, iron 
acquisition), or by a synergic combination of all of these factors 207. Moreover, 
AMPs  ̶  an evolutionary ancient means of defense from microbial pathogens, are 
peptides that are present in, and secreted by neutrophils (and other cell types, 
such as epithelial cells) and act by killing bacteria through recognition and 
disruption of bacterial membrane integrity 204, 208, 209.  
As a successful pathogen, S. epidermidis likely has means to evade host innate 
immune recognition. Both biofilm formation and PIA synthesis play central roles in 
the evasion of host immune defenses by protecting S. epidermidis from PMN 
phagocytosis, AMPs and antibody recognition 69, 210-212. In addition, the S. 
epidermidis protease SepA (33 kDa), via proteolysis 209 and teichoic acids, via 
molecule structural changes 204 also contributes to the AMPs inactivation. 
Furthermore, the agr QS system is also implicated in the regulation of S. 
epidermidis specific immune mechanism of evasion 208, 209. Of note, S. epidermidis 
PSMs (specifically the δ-toxin) have a more pro-inflammatory role like PMNs 
activation and cytokine release, than capacity to lyse neutrophils 206. Combined 
these findings, largely contributes to the understanding of the extraordinary 
success of S. epidermidis as colonizers and infective agents on human. 
Furthermore, it is clear that as a commensal organism living on the human skin, S. 
epidermidis has a more passive defense strategy rather than using aggressive 
toxins 206. 
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1.5. Anti-biofilm therapeutics 
Facing the increased resistance to antimicrobial agents, novel strategies to inhibit 
bacterial attachment and/or colonization of indwelling medical devices by CoNS in 
general, are needed. These strategies include the development of novel 
antibiotics. For instance, daptomycin, quinupristin/dalfopristin and those belonging 
to the oxazolidinone group (such as, linezolid) are included in the novel group of 
antibiotics developed to overcome the resistance problem in CoNS isolates 137. In 
an effort to combat biofilm infections associated with medical devices impregnated 
devices with antibiotic or antiseptics that could prevent bacterial colonization and 
also reduce the use of systemic antibiotics have been explored 26, 213. Moreover, 
these surfaces are inexpensive, have long shelf-lives and most important, do not 
affect the overall function of a device which are major advantages 214. The 
application of topical antibiotics at catheter insertion sites has been also shown to 
prevent staphylococcal infections 213. Importantly, a good antibiotic policy in order 
to reduce the antibiotic pressure will also help to reduce the incidence of multi-
resistant CoNS isolates. Additionally, natural substances as farnesol 215, 216, tea 
tree oil 217 and eucalyptus oil 218 can act as antimicrobial adjuvants or even serve 
as potential alternatives to antibiotics, impairing biofilm growth. 
Another common strategy is to weaken the biofilm structure by degradation of the 
matrix 219. Polysaccharide, eDNA and proteins, are the principal components of 
EPS matrix. Hence, targeting these components via enzymes that degrade each 
of these molecule, such as polysaccharide hydrolases (as dispersin B) 220, 221, 
proteases 222 and/or DNAses 223, 224, can disassemble staphylococcal biofilms. 
Degradation of the matrix eventually leads to biofilm bacterial dispersion. Once 
dispersed, they shift to a planktonic stage and regain more sensitivity to antibiotic 
treatment 104, 225. This combination approach of matrix-degrading agents with 
antibiotics could be very promising. Additionally, the enzyme lysostaphin that 
damage the staphylococcal cell wall detaching biofilms cells appears to be a 
promising agent against S. epidermidis infections 226. Moreover, small-molecule 
inhibitors of basic cell processes like DNA, RNA, and protein synthesis, are some 
of the most effective agents against staphylococci biofilm formation either by 
inhibition or disruption of the biofilm EPS matrix 35.  
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In addition, methods blocking the expression of genes that control S. epidermidis 
adherence or accumulation (such as, icaADBC and aap) to medical devices might 
help to prevent this type of infection. Approaches for targeting the agr QS through 
RIP molecule are also possible and promising 118, 227, 228. Despite slower lytic 
performance, bacteriophages can also be useful as therapeutic agents against S. 
epidermidis biofilm infections 229, 230. 
 
 
1.6. Aims of this study 
S. epidermidis is a commensal inhabitant of the human flora of the skin and its 
pathogenicity is mainly due to the ability to form biofilms on indwelling medical 
devices. In fact, biofilms are a protective mode of growth. Due to adaptive 
mechanisms, S. epidermidis is highly protected against attacks from the host 
immune system and antibiotic treatment, making S. epidermidis infections difficult 
to eradicate impacting patients’ morbidity and mortality 29, 36, 159. Moreover, that 
unique feature seems to be closely related to either commensal or pathogenic S. 
epidermidis lifestyle 12, 26. The physiology of biofilm development appears to be 
very complex and the understanding of how some molecular determinants affect 
the process of biofilm formation and development in S. epidermidis, remain 
uncertain. For instance, the impact of icaA, aap and bhp, in the biofilm formation of 
isolates from different origins is still poorly understood. 
Therefore, this thesis has as its primary objectives: 
I. To characterize molecular and phenotypically a group of Portuguese S. 
epidermidis isolates recovered from patients diagnosed with device-
associated infections; 
II. To in vitro study the interactions between icaA, aap and bhp genes and 
their relative contribution in different stages of biofilm development, in a 
subset of clinical and commensal S. epidermidis isolates. 
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CHAPTER 2 
 
 
 
 
OPTIMIZATION OF S. EPIDERMIDIS BIOFILMS 
QUANTIFICATION AND TRANSCRIPTIONAL 
ANALYSIS TECHNIQUES 
This chapter describes an optimization process of two techniques used during the 
course of this thesis. 
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2.1. Introduction 
The emergence of S. epidermidis as an infectious agent has been correlated with 
the growing number of immunocompromised patients and with the widespread use 
of indwelling medical devices 29, 231. S. epidermidis has a preferential ability to 
adhere to surfaces and to survive as a biofilm 24, 231. This biofilm-forming ability 
plays a key role in the pathogenesis of S. epidermidis and has been associated 
with many hospital-acquired infections, affecting patients’ treatment and increasing 
the costs 3, 232, 233. In fact, the biofilm “mode of survival” brings major benefits since 
not only does it provide structural support to the bacteria, as it also protects them 
from the host immune system 206, 212 and antimicrobial agents 34, 234. 
Due to the impact of biofilms in health, a broad range of techniques have been 
described for specie identification and to in vitro study the biofilm formation. 
However, accurate methods to quantify the total amount of biofilm i.e., bacterial 
cells plus extracellular matrix, are still challenging. For instance, the diagnosis of 
catheter-related bloodstream infection, is made by semi-quantitative roll plate 
method 235 and by disruptive methods, as sonication and vortexing preceding plate 
counting 236. Notwithstanding their clinical usage, these methods involve the 
culture from the catheter tip and subsequent quantification of the number of 
colony-forming units (CFU), which is time consuming. Moreover, CFU evaluation 
has been described as suffering from a lack of reproducibility 237, 238 and can lead 
to significant errors due to the presence of cell clusters promoted by the biofilm 
matrix net. Colorimetric methods such as those using crystal violet (CV) or 
safranin stains, and optical density (OD) measurement of bacterial cultures are 
also common, easy and straightforward quantification techniques 239-241. While 
very useful for screening purposes 242, 243, these methods have major limitations, 
as they tend to underestimate or overestimate the bacterial count. In order to 
overcome this issue, a homogeneous biofilm cell suspension is of major 
importance. Homogeneous suspensions are achieved by vortexing or sonication, 
two methods that demand some optimization and raise some concerns. Studies 
focusing on the elimination of biofilms from infected medical devices have clearly 
demonstrated that either vortexing or scraping do not offer sufficient biofilm 
disruption 244, 245. Conversely, sonication contributes to a better dispersion, making 
the culture after sonication easier to quantify 245-247. Nevertheless, the issue of 
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biofilm maturation has not been taken into account. As we have previously shown 
248, biofilm formation is a dynamic process and mature S. epidermidis biofilms are 
often associated with higher biomass and higher expression levels of adhesins 23, 
thus being more complex to evaluate and/or to eradicate. 
Nowadays, microscopic examination is an accepted gold standard not only for 
biofilm detection and quantification, but also for evaluation of the biofilm formation 
process 249-252. In particular, fluorescence microscopy approaches based on 
fluorogenic dyes offer detailed insights into bacterial biofilms, and have been 
considered as a sensitive and accurate methodology 250, 253, 254.  
In addition to the mentioned methods that rely on traditional approaches, 
advances in molecular technologies – as polymerase chain reaction (PCR) and 
quantitative real-time PCR (pPCR) – have been introduced over the last decades 
and revolutionized our ability to rapidly detect and identify microbial organisms 255, 
256. Indeed, these genetic methods bring major advantages for the quantification of 
fastidious or very slow growing microorganisms 257. For instance, the qPCR is an 
effective and sensitive tool used to investigate the pathogenic role of bacterial 
biofilms 258-260. Nevertheless, this method also has some drawbacks related to 
biofilm sample preparation, mainly due to high content of proteins and 
polysaccharides in the extracellular matrix. Other limitations are the number of 
genes that can be simultaneously analyzed and the associated high costs 261. 
Despite the methods used for quantification, visualization and characterization of 
microorganisms have undergone rapid progress, the results are not linear, and 
depending of the type of microorganism involved, further optimization is still 
needed. 
In order to obtain optimal results the work developed in the scope of this chapter 
aimed at exploring conventional methods to achieve a high-throughput 
quantification of S. epidermidis bacterial biofilms.  
In the sub-chapter 2A, the effect of sonication on the elimination of S. epidermidis 
cell clusters from biofilms developed over time was addressed and the accuracy of 
the three quantification methods was evaluated. Furthermore, a fluorescence 
microscopy automatic counting technique was optimized. In the sub-chapter 2B, a 
custom RNA extraction assay was described and the efficacy among different 
commercial reverse transcriptase kits and qPCR master mixes was assessed. 
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This optimization comprises minimization of time and costs, and maximization of 
reproducibility and sensitivity. 
 
 
2.A. EFFECTS OF SONICATION ON THE ELIMINATION OF S. EPIDERMIDIS CELL 
CLUSTERS FROM BIOFILMS GROWN OVER TIME. 
 
2.A.1. Material and Methods 
Bacterial strains and growth conditions 
Three well-known biofilm-forming strains were used in this study: S. epidermidis 
RP62A (PubMed accession number: PRJNA57663, ID: 57663), S. epidermidis 
9142 262 and S. epidermidis 1457 263. Biofilm cultures of each strain were 
performed in fed-batch mode as previously described 248. Briefly, a starter culture 
was grown overnight in Tryptic Soy Broth (TSB) (Oxoid) at 37 °C with agitation 
(120 rpm, 10 mm orbit diameter, Biosan). In a 24-well plate (Orange Scientific), a 
100-fold dilution was performed in TSB supplemented with 1% (w/v) of glucose 
(TSBg) to induce biofilm formation. The cultures were grown in the same 
conditions for 24, 48, or 72 h. The growth medium was completely removed and 
replaced using an equal volume of fresh TSBg every 24 h. Each experiment was 
repeated at least three times. 
 
Biofilm disruption 
After each incubation time, the biofilm was washed twice, removed from the plate 
by scraping and resuspended in 1 mL of a physiological saline solution (NaCl 
0.9%). Afterwards, biofilm suspensions were sonicated (Cole-Parmer® 750-Watt 
Ultrasonic Homogenizer, 230 VAC, employing a 13mm microtip) using three 
different cycles differing in time (sec) and amplitude (%): cycle A – 10 sec at 30%; 
cycle B – 30 sec at 30% plus 40 sec at 40%, and cycle C – cycle B plus 120 sec at 
40%. The tubes containing the biofilm samples were kept in ice during sonication. 
The scraping procedure removed more than 98% of the biomass, determined by 
the reduction in crystal violet staining. A cell suspension vortexed for 1 min (WS) 
was used as the no-sonication control, as previously described by Olson et al. 264. 
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Biofilm quantification 
Biofilms were quantified using three distinct methods routinely used in 
microbiology. 
I. To determine cell viability, a single biofilm was resuspended in 1 mL of NaCl 
0.9%, followed by sonication or vortexing as described above. Several serial 
10-fold dilutions were made in saline solution and plated on Tryptic Soy Agar 
(TSA). The plates were incubated at 37 °C for 24±2 h before counting the 
number of CFU.  
II. Biofilm biomass quantification was done by measuring the OD595mn of each 
biofilm suspension. Biofilm suspensions were diluted to bring OD into the 
linear range between 0 and 0.8 absorbance units. The measured OD595mn 
was then multiplied by the dilution factor.  
III. Total and dead cells were quantified using a Neubauer chamber coupled with 
an Olympus BX51 epifluorescence microscope equipped with a CCD color 
camera DP71 (Olympus). Biofilm suspensions were stained with the 
commercially available LIVE/DEAD® BacLight™ Bacterial Viability Kit 
(Invitrogen) following the manufacturer’s instructions. A negative control was 
used to determine the baseline threshold for dead cells. Cells were then 
counted at a magnification of 200x using the automated enumeration 
software SigmaScan Pro 5.0 (Systat Software Inc.) as described before 265. 
Briefly, 20 TIFF images (1360 x 1024) per condition were acquired and 
converted to eight bit 256 grayscale, to be analyzed through the differences in 
the gray intensity of each pixel, by using an appropriate intensity threshold 
experimentally determined. Under these conditions, 18420 x 1575 pixels were 
equivalent to 0.0025 cm2 at 200x magnification. 
 
Statistical analysis 
The assays were compared using one-way analysis of variance (ANOVA) by 
applying the Tukey’s multiple comparisons test and the paired sample t-test, using 
SPSS. All tests were performed with a confidence level of 95%. 
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2.A.2. Results and Discussion 
Automatic image counting validation  
Automatic image counting software can be a useful tool in research laboratories 
266, 267, but care should be taken to guarantee that the selected software is 
accurately quantifying the desired object of study. To validate the SigmaScan Pro 
5.0 software for automatic counting of S. epidermidis biofilm cells, using the 
fluorescence-based Live/Dead staining, several and different parameters were 
tested. Firstly, we tested the intensity threshold settings of the software, since it 
has been previously shown that different fluorophores can yield different 
quantification of bacteria 254. To achieve that, several images were manually 
counted by an independent user. Each image was then processed by the software 
by another independent user, without previous knowledge of the manual counting 
results. Three analyses were performed using high, medium and low intensity 
threshold. As illustrated in the figure 2.A.1A, no significant differences (ρ > 0.05) 
were found using any of the three software thresholds and the manual counting. 
This data indicates that the Live/Dead staining was strongly discriminative 
between bacteria and background and that there was no significant fluorophore 
bleach effect that could impair the automatic counts. We have tested the sensitivity 
of the method by using a magnification of either 200x or 400x. Using a 200× 
magnification would not be appropriate for manual counting of S. epidermidis cells 
as it would be nearly impossible to discriminate between the background and 
individual cells, or even between individual cells and small cell aggregates. 
However, as illustrated in the figure 2.A.1B, microscopy quantification of S. 
epidermidis cells using a magnification of 200x is achievable. A further advantage 
of using the magnification of 200x is that with the same amount of images, the 
double of the surface area (as compared with the 400x) can be analyzed. Lastly, 
to discriminate between the two different fluorophores present in Live/Dead 
staining, the total number of live and dead bacteria was determined either by 
manual or automatic counting, using 200x magnification and a medium intensity 
threshold (Fig. 2.A.1C). Both fluorophores were correctly discriminated by the 
software, validating our automatic counting system. 
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Figure 2.A.1: Validation of SigmaScan Pro 5.0 software: (A) Effect of the intensity threshold range 
determination in bacteria quantification, as compared with manual counting. (B) Manual versus automatic 
counting of total and dead cells obtained by using Live/Dead staining. (C) Bacterial quantification by automatic 
counting using a magnification of 400x or 200x. The values represent the mean ± standard deviation of three 
independent experiments. No significant changes were found (ρ > 0.05).  
 
The effect of cell agglomeration in bacterial quantification  
S. epidermidis is known to adhere to multiple surfaces and subsequent cell to cell 
aggregation allows the establishment of biofilms 237, 268. Since biofilm formation is 
considered a major virulence factor of S. epidermidis 231, many studies addressed 
the optimization of methodologies to detach bacteria from infected medical 
implants 236, 246, 247. Sonication is one of the methodologies used 247, 269, 270, which 
have been shown to improve the sensitivity of molecular diagnostic assays, as 
PCR 271, 272. 
In order to address the sonication impact in the viability and quantification of S. 
epidermidis biofilm cells, three different sonication conditions were tested and 
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analyzed by others three conventional used methods: (I) quantification of viable 
cells by CFU plate counting, (II) biomass quantification by OD595mn measurements 
and (III) quantification of total cells by fluorescence microscopy analysis.  
The OD measurements showed a progressive biomass accumulation during the 
analyzed time course of biofilm formation, as anticipated (Fig. 2.A.2). Importantly, 
the different sonication cycles resulted in significant changes in the OD 
measurements in the biofilms with 48 or 72 h of grow. However, in 24 h-old 
biofilms, no differences were found between the three sonication cycles (ρ > 0.05) 
while in more mature biofilms (48 and 72 h of growth), the tested sonication 
conditions progressively influenced biofilm biomass quantification (ρ < 0.05) (Fig. 
2.A.2). Taking into consideration that the linearity of OD determination requires 
homogeneous suspensions, the detected variations suggest the presence of cell 
clusters and pointed out that sometimes a stronger sonication cycle is essential to 
break down those remaining clusters. 
 
 
 
 
 
 
 
 
 
Figure 2.A.2: Bacterial cells quantification by optical density (OD595nm) in biofilm suspensions grown 
over time, following vortexing (WS) or sonication (Cycle A, B and C). The values represent the mean ± 
standard deviation of three independent experiments. Statistical differences (ρ < 0.05) between no-sonication 
control (WS) and any other sonication cycle (θ) and, between the sonication cycle A and the others sonication 
cycles (ϑ) were analyzed with ANOVA Tukey’s test. 
 
Despite the widespread usage, low cost and quickness of this approach, 
quantification of biofilm cells by optical density does not provide accurate insights 
about the total number of bacteria. To address this issue, two other quantification 
methods were tested. Not surprisingly, cell quantification using the microscope 
approach allowed the detection of higher number of S. epidermidis cells in biofilms 
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after 48 or 72 h of growth, comparing to CFU plate count (Fig. 2.A.3). This fact can 
be explained by the ability to accurately differentiate between a cell cluster and an 
individual cell, which would otherwise be considered indistinguishable by CFU 
counting. Only at these later incubation periods, significant differences between 
sonicated and no-sonicated samples were detected (ρ < 0.05). This confirms that, 
in certain conditions, intense vortexing can be used instead of sonication. As a 
vortex is more affordable than a sonicator, some researchers might choose this 
option. However, it was clear that 1 min of vortex was unable to reduce the cell 
clusters size formed in mature biofilms pointed out that, sonication is a more 
effective treatment even at reduced time and lower frequency. Also, the longest 
time and sonication intensity used (cycle C) did not affect the viability of S. 
epidermidis biofilm cells, as validated by live/dead microscopic observations and 
culturability, as determined by CFU (Fig. 2.A.3). While a strong sonication cycle can 
easily kill gram-negative bacteria, gram positive ones withstand higher sonication 
rates 270. Moreover, our results are in agreement with the study performed by 
Joyce et al .273. 
 
 
 
 
 
 
 
 
 
 
Figure 2.A.3: Quantitative results obtained by CFU counting and by fluorescence microscopy in 24 
h-, 48 h-, and 72 h-old biofilms, after each sonication treatment. Bars represent the mean ± standard 
deviation of bacterial cell number within a biofilm sample after its treatment. Results are representative of three 
independent experiments. Statistical differences (ρ < 0.05) between the no-sonication control (WS) and any 
sonication cycle (θ) or between sonication cycle A and other sonication cycles (ϑ) were analyzed with ANOVA 
Tukey’s test. 
 
To determine if our observations could be extrapolated to other S. epidermidis 
strains, we selected two other S. epidermidis biofilm-forming strains (1457 and 
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RP62A) to validate our findings. These strains were selected since they show 
distinct ability to produce biofilm: 9142 and 1457 strains produce a denser and 
crusty biofilm, whereas RP62A produce a smoother biofilm 274.  
As illustrated in the table 2.A.1, similar results were found in comparison to the 
strain 9142, validating the model strain used in this study. Of note, strains 9142 
and 1457 had a significantly higher biomass than RP62A, although those 
differences were not correlated with the CFU count in 72 h-old biofilms. Therefore, 
this can easily be explained by the fact that a biofilm is the sum of bacteria and the 
matrix 24, suggesting that 1457 and 9142 strains may accumulate a denser 
surrounding matrix. 
 
Table 2.A.1: Biomass quantification and viable and total enumeration cells from biofilms of S. 
epidermidis 9142, 1457 and RP62A strains grown for 24, 48 and 72 h. The values represent the mean ± 
standard deviation of 2 to 3 independent experiments. Statistical differences (ρ < 0.05) between OD (*), CFU (ψ) 
and total cells (θ) in the different strains were analyzed with ANOVA Tukey’s test. 
 24 h-old Biofilm 48 h-old Biofilm 72 h-old Biofilm 
9142 strain    
OD595mn 1.61±0.05* 4.02±0.03* 5.84±0.41 
CFU
a
 6.48±0.68E+08 8.18±0.44E+08
ψ
 8.43±1.76E+08 
Total cells
a
 7.40±3.05E+08 1.44±0.06E+09 2.45±0.49E+09 
1457 strain    
OD595mn 1.92±0.07* 5.72±0.33* 6.79±0.23 
CFU
a
 6.15±0.35E+08 6.11±0.12E+08
ψ
 6.63±1.03E+08 
Total cells
a
 8.13±0.30E+08 1.96±0.24E+09 3.37±0.53E+09 
RP62A strain    
OD595mn 0.41±0.01* 1.72±0.04* 2.30±0.03* 
CFU
a
 1.97±0.12E+08
ψ
 4.38±0.16E+08
ψ
 4.45±0.07E+08 
Total cells
a
 2.21±0.41E+08 5.84±0.95E+08
θ
 7.78±0.99E+08
θ
 
 
In all the tested sonication conditions we were able to suspend the biofilm without 
visible cell clusters. By fluorescence microscopy, we found that while the size of 
cell clusters was reduced by increasing the sonication period, they were 
nonetheless, present (Fig. 2.A.4A). As microscopic counting is only feasible with a 
small sampling size, and therefore homogeneity of the suspension is crucial, we 
devised a simple experiment to determine the presence of the microscopic cell 
clusters. This experiment was based on the sedimentation velocity of particles of 
different sizes, as determined by OD readings. Since cell clusters would sediment 
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quicker than individual bacteria, this could be detected as a reduction of the 
OD595mn. As illustrated in figure 2.A.4B, we observed a faster decrease on the OD 
measurements, mainly in mature biofilms, confirming our qualitative microscopic 
observations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.A.4: Effect of bacterial cell aggregates during the time course of biofilm formation: (A) 
Examples of cell clusters observed by fluorescence microscopy. (B) OD595nm measurements over time. Results are 
representative examples of three independent experiments.  
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2.B. OPTIMIZATION OF A QPCR GENE EXPRESSION QUANTIFICATION ASSAY  
 
2.B.1. Material and Methods 
Bacterial strain and growth conditions 
The 9142 S. epidermidis strain previously characterized regarding biofilm 
formation capacity was used in this work 265. The 24 h-old biofilms were formed as 
previously described on the sub-chapter 2.A.1. Biofilms were washed and 
resuspended in 1 mL of 0.9% NaCl. Planktonic bacteria were grown for 18 h in 2 
mL TSB at 37 ºC in an orbital shaker at 120 rpm (10 mm orbit diameter, Biosan). 
 
RNA extraction 
For RNA extraction, two commercially available kits with distinct principles – 
FastRNA® Pro Blue (MPBiomedicals) and PureLinkTM RNA Mini Kit (Invitrogen) – 
were selected and total RNA was isolated according to the manufacturers’ 
instructions. A custom protocol based on the ISOLATE RNA Mini kit columns 
system (Bioline) was also optimized. Briefly, bacteria were first resuspended in 
100 mL RNase free water and transferred to a 2 mL safe lock tube containing 0.4 
grams of acid washed 150–212 mm silica beads (Sigma), 400 mL Lysis buffer R 
(provided by the kit) and 400 mL 90% phenol solution (AppliChem) were then 
added. This mixture was vortexed for 20 sec before using the FastPrep® cell 
disruptor (BIO 101, ThermoElectron Corporation, Thermo Scientific), with setting 
6.5 for 35 sec. The beat-beading step was repeated twice and the samples were 
cooled on ice for 5 min between steps. Samples were centrifuged at 16,000 g for 5 
min and supernatants transferred to a new tube and mixed with equal volume of 
100% ethanol (Fisher Scientific). The samples were them transferred to the silica 
columns and centrifuged at 12,000 g for 15 sec. The flow-through was discarded 
and each column was reinserted into a new collection tube. 700 mL of Wash buffer 
I were added to each column and centrifuged at 12,000 g for 15 sec. The flow-
through was discarded, the column was inserted into the same collection tube and 
500 mL of Wash buffer II were added to each column, and centrifuged at the same 
conditions. The flow-through was discarded and the columns reinsert into a new 
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collection tube, for a new centrifugation. The collection tube was discarded and 
each column was inserted into a recovery tube. Finally, RNA elution was achieved 
by adding 45 mL of RNAse-free water, incubated for 1 min and then centrifuged 
for 1 min at 12,000 g. All steps were done at room temperature, except where 
otherwise noticed.  
 
DNase I treatment and RNA quality determination 
After RNA extraction, a DNase I (Fermentas) treatment step was included to 
digest remaining genomic DNA (gDNA). Briefly, 5 µL of reaction buffer and 2 µL of 
DNAse I were added to each sample of RNA and incubated for 30 min at 37 ºC. 
To inactivate the DNAse I endonuclease, 5 µL of 25 mM EDTA were added to the 
reaction mixture, which was then incubated at 65 ºC for 10 min.  
The RNA quality and quantity were determined by agarose gel electrophoresis and 
by measuring the absorbance at 260 and 280 nm using the NanoDrop 1000TM 
Spectrophotometer (ThermoScientific). Electrophoresis was carried out in a 
horizontal 1.5% agarose gel, containing ethidium bromide. The gel was visualized 
under a Gel Doc™ 2000 system (Bio-Rad). 
 
Complementary DNA (cDNA) synthesis 
cDNA synthesis was performed using 4 different commercial kits: Super Script® 
VILOTM (Invitrogen), RevertAaidTM First Strand cDNA Synthesis kit (Fermentas), 
iScriptTM cDNA synthesis (Bio-Rad) and qScriptTM cDNA Synthesis (Quanta 
BioSciences). Briefly, total RNA was normalized to 500 ng, mixed with 10 pmol of 
each reverse primer to a final volume of 20 µL, incubated for 5 min at 65 ºC and 
chilled on ice. The normalized RNA was reverse transcribed in two final reaction 
volumes: 20 µL and 10 µL. The 20 µL volume reactions contained the following: 4 
µL of 5x RT buffer, 10 mM dNPTs mix, 200 U of Reverse Transcriptase enzyme, 
20 U of RiboLock RNAse inhibitor, half of the normalized RNA pre-mixture and 
nuclease free water up to 20 µL. The 10 µL reactions contained half the 
corresponding volumes. The cDNA mixture was then incubated for 60 min at 42 ºC 
followed by 10 min at 70 ºC. To determine the possibility of gDNA carry-over, 
control reactions were performed under the same conditions, but lacking the 
reverse transcriptase enzyme (no-RT control).  
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Quantitative real time PCR (qPCR) 
The qPCR analysis was performed using 4 different commercial qPCR master 
mixes: mi-real-time EvaGreen® Master (Metabion), Maxima® SYBR Green Master 
Mix (Fermentas), iQTM SYBR® Green Supermix (Bio-Rad) and PerfeCTa® 
SYBR® Green SuperMix (Quanta BioSciences). A 100-fold dilution of the resulting 
cDNA template was used for qPCR analysis of icaA gene-specific primers and 
both 20 and 10 µL reaction volumes were performed. The 20 µL reaction 
contained 2 µL diluted cDNA or no-RT control, 10 pmol of the primer (16S: FW: 5' 
– GGGCTACACACGTGCTACAA – 3' and RV: 5' – GTACAAGACCCGGGAACGTA – 3'; icaA; 
FW: 5' –TGCACTCAATGAGGGAATCA – 3' and RV: 5' – TAACTGCGCCTAATTTTGGATT – 3'), 
6 µL nuclease free water, and 10 µL of the respective master mix. The 10 µL 
reactions contained half the corresponding volumes. qPCR run was performed on 
a CFX 96 (Bio-Rad) as follow: 95 ºC for 30 s, 39 cycles of 95 ºC for 5 sec, 60 ºC 
for 15 sec and 68 ºC for 15 sec. Relative fold increase of icaA in biofilms 
compared to the planktonic cultures was normalized to the expression of the 
internal control gene (16S). qPCR products were analyzed by melting curves for 
unspecific products or primer dimer formation. Relative fold increase of specific 
mRNA transcripts was calculated using 2DCt method, a variation of the Livak 
method, where 2 stands for the 100% reaction efficiency (the reaction efficiency 
was determined experimentally and thus 100% efficiency was replace by the real 
efficiency) and DCt =Ct (housekeeping gene)-Ct (target gene). The values of the 
PCR efficiency calculated to each master mix were: 84±4% for iQTM SYBR® 
Green, 84±7% for Maxima® SYBR Green, 78±5% for PerfeCTa® SYBR® Green 
and 87±6% for mi-real time EvaGreen® master mix. The data analysis was based 
on at least three independent experiments. 
 
Statistical analysis 
The assays were compared using one-way analysis of variance (ANOVA) by 
Tukey’s multiple comparisons test and the paired sample t-test, using SPSS. All 
tests were performed with a confidence level of 95%. 
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2.B.2. Results and Discussion 
RNA extraction 
The RNA extraction was first performed using the commercial FastRNA® Pro Blue 
kit (MPBiomedicals), which combines mechanical and chemical lysis together with 
organic extraction. We then repeated the process using the PureLinkTM RNA Mini 
Kit (Invitrogen) that uses an enzymatic lysis and silica membrane extraction. In 
addition, a customized protocol based on both mechanical and chemical lysis, 
required to effectively extracting the RNA from S. epidermidis biofilms, with 
subsequent silica membrane isolation that will reduce the time needed for RNA 
extraction 275, was performed. This custom approach was tested with 4 different 
column systems as follow: ISOLATE RNA Mini kit columns system (Bioline), 
PureLinkTM RNA Mini Kit (Invitrogen), Direct-zolTM RNA MiniPrep (Zymo Research) 
and FavorPrepTM Blood/Cultured Cell Total RNA (Favorgen). 
The PureLinkTM kit was the RNA extraction kit that yielded the poorer results (Fig. 
2.B.1). However, when combined the PureLinkTM column system with the custom 
lysis we were able to improve the RNA yield up to similar values than those 
obtained with FastRNA® Pro Blue kit. All the other column systems tested resulted 
in high RNA yield. The absorbance ratio A260/A280 shows that all RNA extraction 
procedures resulted in acceptably low levels of protein contamination. Some of the 
kits presented an A260/A230 ratio below 1.8, indicating possible contamination 
with polysaccharide, phenol and/or chaotropic salts. Despite the importance of 
such parameters in RNA quality determination, they have trivial implications in the 
stability and reliability of gene expression assays 276. 
Regarding the RNA quality and yield, none of the custom protocols exceed the 
FastRNA® Pro Blue kit. However, the reduction of costs and preparation time 
were also taken into account. As listed in table 2.B.1, with our custom RNA 
protocol we could achieve a 75% and 68% reduction of time and cost per reaction, 
respectively, in comparison with FastRNA® Pro Blue kit. 
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Figure 2.B.1: Comparison of RNA yield and purity obtained by the different RNA extraction 
procedures used. The values represent the mean ± the standard deviation of 3 independent experiments.  
 
 
Table 2.B.1: Costs associated with kits and reagents used for the RNA extraction. All the prices listed 
were obtained by quote during January 2012. 
Reagents and Kits (Manufacturer) 
Number of 
reactions per kit 
Prices (€) per 
reaction 
FastRNA® Pro Blue (MPBiomedicals) 50 7.14 
PureLink
TM
 RNA Mini Kit (Invitrogen) out-50 9.70-4.46 
ISOLATE RNA Mini Kit  (Bioline) 10-250 5.30-3.68 
Direct-zol
TM
 RNA MiniPrep (Zymo Research) 50-200 4.19-3.41 
FavorPrep Blood/Cultured Cell Total RNA (Favorgen) 50-300 2.50-1,80 
Ethanol 100% (Fisher) 2500* 0.006 
Chloroform (Fisher) 3333-8333 0.002-0.001 
Phenol (AppliChem) 277-1387 0.08-0.06 
Glass beads, acid-washed, 150-212 mm (Sigma) 25-1250  1.53-0.33 
RNAse & DNAse free tubes with screwcap (BioPlastics) 500 0.12 
 
cDNA and qPCR reaction optimization 
The performance of different reverse transcriptase kits and qPCR master mixes 
commercially available were tested. Using the cDNA synthesized by different kits, 
icaA gene expression was quantified by qPCR with distinct master mixes. 
Interestingly, significant differences in icaA mRNA levels were found when varying 
the reverse transcriptase kits (ρ < 0.05), but no changes were observed when 
different qPCR master mix are used (ρ > 0.05), excepted in the case of 
RevertAaidTM First Strand cDNA Synthesis kit as illustrated in figure 2.B.2. 
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Figure 2.B.2: The impact of different cDNA and qPCR commercial kits in icaA gene expression 
quantification. The values represent the mean ± standard deviation of 3 independent experiments. Statistical 
differences (p < 0.05) between cDNA kits (ϑ) or qPCR master mixes (θ) were analyzed with ANOVA Tukey’s test. 
 
Reduction in the reverse transcriptase and qPCR volume reaction are among the 
possible ways to reduce costs associated with gene expression analysis. 
However, smaller volumes may introduce more pipetting errors. In order to 
determine if a reduction in cDNA reaction volume could impair the qPCR results, 
and vice-versa, the RNA extracted from both S. epidermidis planktonic and biofilm 
cultures were first reverse transcribed using the four cDNA synthesis kits with 
either 10 or 20 µL of volume and then quantified with 20 µL volume reaction of 
Maxima® SYBR Green Master Mix (Fig. 2.B.3A). Simultaneously, qPCR 
commercial kits were used with both 10 and 20 µL final reaction volumes, using as 
template the reverse transcribed RNA obtained from a 20 µL reaction with 
RevertAidTM First strand cDNA synthesis kit (Fig. 2.B.3B).  
As observed in the figure 2.B.3, the variation of qPCR volume did not affect the 
quantification of icaA gene expression (p > 0.05). On the other hand, regardless 
the different cDNA kits used, a significant variation was found in the cDNA 
obtained using SuperScript® VILOTM cDNA. 
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Figure 2.B.3: Variation in icaA gene expression quantification using different cDNA (A) or qPCR (B) 
reaction volumes. (A) cDNA synthesized using either 20 µL or 10 µL reaction volumes was used for icaA 
transcripts quantification. The transcripts were detected using Maxima® SYBR Green Master Mix. (B) cDNA 
synthesized using RevertAidTM First Strand cDNA synthesis kit (20 µL reaction) was used for icaA transcripts 
quantification by different qPCR master mixes and using 20 µL or 10 µL final reaction volumes. The values 
represent the mean ± standard deviation of 3 independent experiments. Statistical differences (p < 0.05) between 
10 µL and 20 µL reactions (θ) were analyzed with paired t-test. 
 
 
2.2. General conclusions 
The chapter 2 introduces some of the most used methods in clinical and research 
microbiology laboratories to assess bacterial quantification in catheter-related 
infections. The sensitivity of diagnostic assays has been improved in the last years 
through introduction of techniques that remove adherent biofilm bacteria from the 
medical implant 236, 269, 277. Despite the new improvements, the diagnosis of these 
infections is still difficult. Molecular and image techniques have also been 
accepted as more sensitive tools for improving the diagnosis of these infections 
242, 252, 272. Moreover, both conventional culture and molecular methods can be 
complementary, but biofilm samples are still challenging. The surrounding matrix 
confers complexity to biofilm cells, hampering quantification methods by either 
promoting cells clusters or contributing to a source of genetic material 
contamination. Also, optimum conditions to effectively break and properly quantify 
the biofilm need to be optimized. In this particular case, biofilm and gene 
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expression quantification methods were adapted and optimized in order to reach 
optimal and feasible results when applied to S. epidermidis in vitro biofilms. 
Establishment of clusters is a paramount issue in the usage of conventional 
methods to quantify cells from biofilms. To circumvent this issue, we started by 
testing the effect of different sonication conditions in young (24 h-old) or mature 
(48 and 72 h-old) biofilms and evaluated its effect in the quantification outcome 
using three distinct methods. Despite the limitations of CFU count and OD 
measurements, the addition of a sonication step promoted some technical 
improvements. We also tested an automatic image counting software, in 
association with fluorescence-based microscopy, in order to accurately and quickly 
quantify the number of S. epidermidis total and viable biofilm cells. While some 
further optimization is still needed, our semi-automatic counting has proven to be 
robust a method and brings important advantages 254, 266, 267. The speed of 
processing is of upmost importance, as manual counting is time consuming. 
Furthermore, by applying the same settings, automatic counting is more reliable, 
since it does not depend on user to user interpretation variability. 
We also addressed the issue of reliable gene expression within S. epidermidis 
biofilms. We demonstrated that it was possible to achieve a robust gene 
expression protocol by customizing some commercial available kits, with a 
substantial reduction of the economic cost of the experiment. We also showed that 
the reduction of either cDNA or qPCR volume reaction are among the possible 
ways to reduce costs associated with gene expression analysis without 
compromising the reproducibility and accuracy of the method. 
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CHAPTER 3 
 
 
 
 
MOLECULAR AND PHENOTYPICAL 
CHARACTERIZATION OF S. EPIDERMIDIS 
ISOLATED IN A PORTUGUESE HOSPITAL 
This chapter provides a general characterization of 86 Portuguese clinical isolates 
of S. epidermidis regarding the ability of each isolate to form biofilm and the 
carriage of biofilm-related genes. The antibiotic resistance and its association with 
clinical, phenotypic and molecular features were also pointed out. 
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3.1 Introduction 
Owing to multidrug resistant organisms and financial impact to the communities, 
healthcare-associated infections (HAIs) represent today’s a significant problem in 
healthcare facilities worldwide, impairing patient’s quality of life 5, 6. These 
infections are associated with a variety of risk factors that includes the catheter 
insertion site itself and surgical procedures 9, 12. The length of catheterization and 
the overuse or improper use of antibiotics, are also associated to significant 
morbidity and mortality mostly among immunocompromised and critically ill 
patients or very young and very old people 1, 3, 7. Furthermore, transmission of 
infectious diseases between healthcare workers and patients is also very common 
7. The risk increase, if the causative organism has developed resistance to a 
number of antimicrobial agents 5, 9. Although a natural phenomenon 278, antibiotic 
resistance is accelerated by use of antimicrobial drugs and can eventually lead to 
failed treatments and/or deaths, as well as and growing healthcare costs 6, 278. In 
fact, the emergence and spread of highly-resistant bacteria is now a major threat 
to public health and is widely recognized, by the three most important international 
health organizations, as a serious global problem 7, 278, 279. HAIs, that usually occur 
two to three days after admission to hospital 280, account for 5 to 10% of all 
hospital admissions 5, 7. The two most recent Portuguese national surveillance 
reports, concerning healthcare infections, account for an overall prevalence of 
11.4% in 2009 281 and 10.6% in 2012 10, the highest among European countries 7.  
A part of the human skin microbiota, the coagulase-negative bacterium S. 
epidermidis is now considered, an opportunistic pathogen responsible for many 
HAIs, mainly those related to indwelling medical devices (such as, prosthetic 
joints, cardiac pacemakers and mechanical heart valves, artificial lenses, central 
venous catheters cerebrospinal fluid shunts, among others) 1, 12, 282. With an 
isolation rate of approximately 7% among all HAIs and the most frequently isolated 
microorganism in bloodstream infection 7, S. epidermidis is considered one of the 
most adaptable nosocomial human pathogens 11, 12. Due to the capacity to 
accumulate multiple antibiotic resistance determinants by genetic recombination 
and gene acquisition 28, multidrug resistance (MDR) is increasing among 
Staphylococcal species leading to a major health concern not only in Portugal but 
in all industrialized countries 7, 278. For instance, the S. epidermidis resistance to 
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methicillin/oxacillin (MRSE) encoded by mecA gene, currently exceeds 70% in 
many institutions worldwide 283-287. In Portugal, a recent study revealed mecA 
prevalence, among Portuguese S. epidermidis isolates, to be 79.8% 155. Antibiotic 
resistance is therefore accelerated by the use of antimicrobial drugs and can 
eventually lead to failed treatments and in some case, deaths 7, 278, as well as 
growing healthcare costs 6, 278. Although antimicrobial resistance compromise 
therapy, biofilm formation enhances this problem by affecting the efficacy of the 
administrated treatment leading to persistent infections, compromising patient 
safety 26. In the recent years, indwelling medical devices have been crucial in the 
improvement of patient care however this progress, in an inadvertently manner, 
also predisposed patients to biofilm-related infections 12, 26. The ability to form a 
community of adherent microorganisms encased in a self-produced extracellular 
matrix (termed biofilm) is considered the major determinant of S. epidermidis 
virulence 23. S. epidermidis strains are known to vary in their ability to form biofilms 
and several genes have been shown to take a part in this complex process 28, 288. 
Among these, the most extensively studied are in the icaADCB operon (ica, 
intercellular cluster adhesin) which is responsible for the synthesis of 
polysaccharide intercellular adhesin (PIA), a major component of the biofilm 
matrix, directly impacting in the biofilm accumulation 289. Besides icaADBC operon, 
the aap (accumulation-associated protein) 290 and bhp (biofilm-homologous S. 
aureus protein) 89 genes are also involved in and considered important genetic 
determinants of S. epidermidis biofilm formation in a PIA-independent manner. 
Additionally, icaA, aap and bhp genes are all involved in sessile biofilm cell 
proliferation and maturation 26, 88, thus being major contributors to biofilm 
development and persistence. 
Despite the importance and clinical significance, there is a lack of available 
information relating epidemiology data to the molecular and phenotypic 
characteristics of S. epidermidis clinical isolates in Portugal, mainly related to 
biofilm formation and antimicrobial susceptibility.  
Here, we determined the phenotypic and molecular characteristics of S. 
epidermidis isolates recovered from patients diagnosed with device-related 
infections, over a 30-month period. Their antibiotic resistance profile as well as its 
association with phenotypic and genotypic biofilm-associated determinants was 
also assessed. To the best of our knowledge this was the first study performed 
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with Portuguese clinical isolates that correlates the biofilm forming capacity to the 
antimicrobial resistance pattern. Importantly, although surveillance allow the 
determination of infection rate and the assessment of the effectiveness of 
interventions, the phenotypic and molecular characterization of clinical isolates 
may improve the management of those preventive strategies and be useful for a 
better understanding of the epidemiology of S. epidermidis associated infections. 
 
 
3.2 Material and Methods 
Isolation of clinical S. epidermidis isolates 
A total of 86 S. epidermidis isolates were collected from January 2011 to June 
2013 in the Microbiology Laboratory of the Hospital de Santo António, a 700-bed 
tertiary-care public hospital in Porto (Portugal) that handles about 35 000 
inpatients admissions per year. All clinical isolates came from patients aged from 
newborns (≤ 1 year-old) to 94 year-old with a diagnosis of HAIs associated to 
device colonization, clinically and laboratorial confirmed, following Infectious 
Diseases Society of America guidelines 291. Additionally, HAIs were defined as a 
localized or systemic condition resulting from an adverse reaction to the presence 
of an infectious agent(s) or its toxin(s) in accordance with CDC (Centers for 
Disease Control and Prevention) criteria 280. That condition occurred 48 hours or 
more after hospital admission and was neither present nor incubating at the time 
of admission 280. Patients clinical and demographics data were collected under 
approval of Ethics Committee Board of Hospital de Santo António, Porto Hospital 
Centre, Portugal (Reference 015/09: 014-DEFI/014-CES). 
 
Identification of clinical S. epidermidis isolates 
Each isolate was identified at the species level using the commercially available 
VITEK® 2 identification system using the gram-positive ID card (BioMérieux) and 
subsequently by matrix assisted laser desorption ionisation – time-of-flight (MALDI-
TOF; BioMérieux), according to the manufacturer’s instructions.  
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Antimicrobial susceptibility testing 
Susceptibility to penicillin, clindamycin, erythromycin, daptomycin, fusidic acid, 
fosfomycin, gentamicin, levofloxacin, moxifloxacin, linezolid, rifampin, tetracycline, 
tigecycline, vancomycin, teicoplanin and trimethoprim-sulfamethoxazole was 
determinate by VITEK® 2 using the P619 panel according to the Clinical and 
Laboratory Standards Institute (CLSI) recommendations. Results for each clinical 
isolate was reported using the category interpretations “susceptible”, 
“intermediate” and “resistant”. S. epidermidis isolates were considered as 
multidrug resistant (MDR), if non-susceptible to at least one agent in 3 or more 
antimicrobial categories according to standardized international terminology 292. 
 
Quantification of biofilm formation 
Biofilm cultures of each strain were performed in batch mode as previously 
described in chapter 2 with minor modifications. Briefly, a starter culture was grown 
overnight in TSB (Liofilchem) at 37 °C with aeration and agitation (120 rpm, 10 mm 
orbit diameter, Biosan). Overnight cultures were adjusted to an OD at 640 nm of 
0.25-0.3 corresponding to 2x10
8 CFU per mL. Subsequently, 200 μL of 100-fold 
dilution performed in TSB supplemented with 0.4% (w/v) of glucose to induce 
biofilm formation, was placed in a 96-well plate (Orange Scientific) and incubated 
in the same conditions as the starter culture for 24 hours. Furthermore, 
quantitative determination of biofilm formation was performed as previously 
described by Stepanovic et al. 240 with some modifications. Briefly, after incubation 
time, the bacterial cells in suspension were carefully removed and each well was 
washed twice with 200 μL of 0.9% of NaCl. Afterwards, 100 μL of 99.9% methanol 
(Fisher Scientific) was added to each well and let it in for 15 min in order to fix the 
biofilm. Methanol was then removed and the plate was left to air dry. The fixed 
bacteria biofilm cells were stained with 200 μL of 1% (v/v) CV (Merck) per well, for 
5 min. Excess crystal violet was removed by gently washing each well twice with 
distilled water and filled with 160 μL of 33% (v/v) glacial acetic acid (Fisher 
Scientific) in order to solubilize the CV. Absorbance was measured at 570 nm 
(OD570 nm) using a ELISA plate reader (Tecan). Additionally, 4 well per plate with 
sterile TSB alone were used to check for medium sterility and also served as 
negative controls in this assay. Sixteen replicates of each isolate per biofilm assay 
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were included and a minimum of three independent assays were carried out. 
Moreover, a biofilm producer strain (S. epidermidis RP62A) and a non-biofilm 
producer (S. epidermidis ATCC 12228) were also included. The optical density of 
each isolate was compared with the mean absorbance (OD570 nm < 0.26) of the 
negative control (ATCC 12228) and the ordinal classification for the level of biofilm 
production proposed by Stepanovic et al. 240 was used in order to simplify the data. 
 
Gene detection by PCR 
One to five bacterial colonies of each isolate were inoculated from a TSA agar 
plate into 200 μL of nuclease-free water. The cells were lysed by heating at 95 °C 
for 10 min followed by 5 min on ice. Cellular debris was removed by centrifugation 
at maximum speed for 5 min. One μl of the collected supernatant was used as 
template for PCR amplification. For single target amplification, the PCR was 
performed in the MJ Mini thermal cycler (Bio-Rad) with a final volume of 10 μL of 
final volume and containing 5 μL of DyNAzyme II PCR Master Mix 2x 
(Finnenzymes), 1 μL of primer mixture with a 10 μM concentration each and 2 μL 
of nuclease-free water. The primers sequences of the virulence-associated genes 
used in this study are listed in table 3.1. The PCR program consisted of an initial 
denaturation step at 94 °C for 5 min, followed by 35 cycles of DNA denaturation at 
94 °C for 30 sec primer annealing at 56 °C for 30 sec, and primer extension at 72 
°C for 45 sec. After the last cycle, a final extension step at 72 °C for 10 min was 
added. Total PCR products were analyzed by gel electrophoresis with 2% agarose 
(Bio-Rad) stained with Midori Green DNA stain (Nippon Genetics Europe GmbH) 
and visualized by GelDoc® 2000 (Bio-Rad). A 100-bp DNA ladder (NZYTech) was 
used as a marker. A mock PCR reaction lacking the DNA template was prepared 
and used as a negative PCR control. In addition, S. epidermidis RP62A was 
included as positive PCR control and the rpoB gene was used as an internal 
control in each PCR run. S. epidermidis isolates were considered to harbor any of 
the tested genes if having at least one positive PCR result. 
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Table 3.1: Oligonucleotide sequences used in PCR gene amplification. 
Gene Oligonucleotide sequence (5’ to 3’) PCR product size (bp) 
PCR amplification of methicillin-resistance gene 
mecA set 1 
Fw: CCG AAA CAA TGT GGA ATT GG 
600 
Rv: TCA CCT GTT TGA GGG TGG AT 
mecA set 2 
Fw: GGC CAA TAC AGG AAC AGC AT 
425 
Rv: CTG CAA CGA TTG TGA CAC G 
PCR amplification of biofilm-associated genes 
icaA set 1 
Fw: TGC ACT CAA TGA GGG AAT CA 
417 
Rv: TCA GGC ACT AAC ATC CAG CA 
icaA set 2 
Fw: TGC ACT CAA TGA GGG AAT CA 
132 
Rv: TAA CTG CGC CTA ATT TTG GAT T 
aap set 1 
Fw: GCT CTC ATA ACG CCA CTT GC 
617 
Rv: GGA CAG CCA CCT GGT ACA AC 
aap set 2 
Fw: GCA CCA GCT GTT GTT GTA CC 
199 
Rv: GCA TGC CTG CTG ATA GTT CA 
bhp set 1 
Fw: TGG ACT CGT AGC TTC GTC CT 
213 
Rv: TCT GCA GAT ACC CAG ACA ACC 
bhp set 2 
Fw: CGT TCC CTT GAT TGA GGT GT 
404 
Rv: GTT ACG TGA ACG GGT CGA TT 
Legend: bp, base pair; Fw, forward; Rv, reverse. 
 
Statistical analysis 
Comparison of categorical variables was performed using Fisher´s exact test and 
Pearson´s chi-squared test (χ²) using SPSS Statistical software version 17.0 
(SPSS Inc.). The Fisher´s exact test was used to test for association and the χ² 
was used to analyze the quantitative variables. Level of significance was set at p-
value ≤ 0.05 and all tests were two-tailed.  
 
 
3.3 Results 
Study population and clinical characteristics 
Over a 30-month period, 86 isolates of S. epidermidis were collected from patients 
with a diagnosis of device-related infection and treated in a tertiary-care hospital in 
Portugal’s second major city (Porto). The rate of HAIs in this hospital during the 
time course of this study is described in the table 3.2. The prevalence rate was in 
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average 10.1%. Overall, urinary tract and respiratory infections were the most 
prevalent ones.  
 
Table 3.2: Time-trend analysis of HAIs rate: clinical prevalence versus laboratory-confirmed. 
Hospital Parameters (%) 
Prevalence ratea 2011 2012 2013b 
Total  10.7 / 9.4 9.7 / 9.4 11.2 
Urinary tract infection 2.2 / 2.6 2.4 / 3.1 2.8 
Bloodstream infection  1.5 / 0.8 1.2 / 2.4 1.1 
Respiratory tract infection  3.7 / 3.1 2.5 / 0.8 3.9. 
Surgical infection  2.2 / 1.1 0.8 / 1.6 1.7 
Other  1.1 / 1.8 2.8 / 1.5 1.7 
Laboratory based clinically validated incidence rate 
   
Total infections per 1000 day inpatient 4.7 4.2 4.9 
Total 2.1 2.0 2.5 
Urinary tract infection rate  1.0 1.0 1.4 
Bloodstream infection rate  0.3 0.3 0.3 
Respiratory tract infection rate  0.5 0.4 0.5 
Surgical infection rate  0.2 0.2 0.2 
Others  0.1 0.1 0.4 
a
 The prevalence rate is evaluated two times a year (1
st
 semester / 2
nd
 semester) 
b
 Values correspond only to the first semester of 2013 
 
Of the 86 studied patients, 49 (57.0%) were men and the mean age was 46 years 
(95% CI, 39.1 – 53.2%) range from newborns to 94 years old (Table 3.3). The 
distribution of infections in this public teaching hospital was 24.4% in newborns (≤ 
1 year, n = 21) and major (39.5%, n = 34) in elderly patients with 65 or more years, 
following the same tendency of the overall healthcare facilities in Portugal 10. 
Furthermore, at least 33.7% (n = 29) of our study population were 
immunocompromised patients. The most common co-existing conditions were 
cancer (16.3%, n = 14), dialysis (9.3%, n = 8) and chronic infections (3.5%, n = 3). 
Sepsis was diagnosed in 34.9% (n = 30) of the patients. Twenty-eight patients 
(32.6%) didn’t receive any antibiotic therapy while from 10 patients (11.6%) no 
information was available prior to identification of the causative bacterium. 
Preceding S. epidermidis infection recovery, the number of patients receiving at 
least one antimicrobial agent increased up to 84.9% (n = 73) with major frequency 
in elderly patients (39.7%, in which 48.3% of these were under combined therapy). 
The most prescribed drug was vancomycin (53.5%), followed by amikacin (11.6%) 
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and imipenem (10.5%). Six patients (7.0%) were still without any specific antibiotic 
therapy after S. epidermidis isolation while from 7 patients (8.1%) we had no 
available information. 
 
Table 3.3: Clinical parameters of the 86 patients diagnosed with device-related infections. 
Patients Clinical Parameters 
Demographic characteristics  
 
Mean age (years) 46 
≤1 year (% of patients) 24.4 
>65 years (% of patients) 39.5 
Male gender (% of patients) 57.0 
Average length of hospitalization from admission to S. epidermidis isolation (no. of Days) 25 
Underlying condition (% of patients) 
 
Immunocompromised (total) 33.7 
Cancer 16.3 
Hemodialysis 9.3 
Chronic infections 3.5 
Under antibiotic therapy (% of patients) 
 
Pre-culture  55.8 
Post culture  84.9 
Source (% of isolates) 
 
Blood 84.9 
CVC 10.5 
Other 4.7 
 
Regarding the type of healthcare-associated infections (Fig. 3.1), central line-
associated bloodstream infections (CLABIs) were by far the most frequently 
reported during the period under study, accounting for 60.5% (n = 52) of all clinical 
infections, while catheter-associated urinary tract infections (CAUTIs) and 
respiratory tract infections respectively accounted for 18.6% (n = 16) and 12.8% (n 
= 11). Furthermore, CLABIs were similarly distributed among the different age 
groups rather than CAUTIs that were more prevalent among elders (68.8%). 
Surgical-site infections (5.8%, n = 5) and skin and soft tissue infections (2.3%, n = 
2) were less prevalent infections in our population of study. In addition, there was 
no association (p > 0.05) between age, sex and clinical characteristics and/or 
incidence of S. epidermidis infections. 
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Figure 3.1: Type of HAIs related to the 86 S. epidermidis clinical isolates included in this study. 
 
Antimicrobial susceptibility characteristics 
Seventy-five (87.2%) S. epidermidis clinical isolates harbored mecA. The mecA 
gene encodes the altered penicillin-binding protein 2a and is associated with the 
methicillin resistance (MRSE) pattern 293. Moreover, S. epidermidis isolates lacking 
mecA were considered as methicillin-susceptible S. epidermidis (MSSE). The 
analysis of antimicrobial susceptibility profiles (Table 3.4) has shown higher levels 
of resistance to β-lactam antibiotics (penicillin; 96.3%, n = 82), erythromycin 
(79.1%, n = 68), gentamicin (69.8%, n = 60) and tetracyclin (69.8%, n = 60). All S. 
epidermidis clinical isolates were susceptible to vancomycin, daptomycin and 
tigecycline. Linezolid (96.5%, n = 82) and fosfomycin (94.2%, n = 81) also 
demonstrated high levels of susceptibility. Seventy-two (83.7%) clinical isolates 
showed a high rate of susceptibility to teicoplanin whereas the others 14 (16.3%) 
isolates demonstrated an intermediary phenotype. 
Additionally, the levels of non-susceptible to at least one agent in 3 or more 
antimicrobial categories hence considered as MDR, were unexpectedly high, 
affecting 86.0% of S. epidermidis clinical isolates included in this study. The MDR 
phenotype (p = 0.001) was observed among 68 MRSE (91.9%) and 6 MSSE 
(8.1%) clinical isolates. Interestingly, sixty-three (86.3%) patients, receiving at 
least one antimicrobial agent, were infected by MDR isolates suggesting that 
susceptibility profile of the isolated strain should be considered for therapy. A 
B lo o d s tre a m  in fe c t io n s
U r in a ry  tra c t in fe c t io n s
R e s p ira to ry  t ra c t  in fe c t io n s
S u rg ic a l s ite  in fe c t io n s
S k in  a n d  s o ft  t is s u e s  in fe c t io n s
60.5%
18.6%
12.8%
5.8%
2.3%
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positive association (p = 0.035) was also found among patients under antibiotic 
therapeutic and MRSE isolates (90.4%, n = 66). Furthermore, the MDR phenotype 
was equally distributed among the different age groups and when combining the 
results, no association (p > 0.05) was found between the MDR phenotype and the 
underlying medical condition. 
 
Table 3.4: Antimicrobial susceptibility profile of S. epidermidis isolates included in this study. 
Antibiotics 
Non-susceptible 
isolates (%) 
Penicillin (n =82) 96.3 
Erythromycin (n = 86) 79.1 
Fusidic acid (n = 86) 75.5 
Levofloxacin (n = 86) 70.9 
Gentamicin (n = 86) 69.8 
Tetracycline (n = 86) 69.8 
Clindamycin (n = 86) 58.1 
Trimethoprim-sulfamethoxazole (n = 85) 42.4 
Moxifloxacin (n = 86) 32.6 
Rifampin (n = 86) 31.5 
Teicoplanin (n = 86) 16.3 
Fosfomycin (n = 86) 5.8 
Linezolid (n = 85) 3.5 
Tigecycline (n = 86) 0.0 
Vancomycin (n = 86) 0.0 
Daptomycin (n = 67) 0.0 
Multidrug resistance (n = 86) 86.0 
 
Phenotypic and virulence-associated genetic traits  
Biofilm formation is a common phenotypic feature of S. epidermidis. In order to 
assess the ability to form biofilm of each clinical isolate, a biofilm-forming strain 
(RP62A; OD570 nm = 1.08) and a non-biofilm producer (ATCC 12228) were used as 
positive and negative controls, respectively. S. epidermidis solates with an optical 
density minor than or equal to S. epidermidis ATCC 12228 (OD570 nm < 0.26) were 
considered non-biofilm producers (NP). S. epidermidis isolates were divided into 
four groups depending on whether they produce a strong and fully establish biofilm 
(SP), a moderate or weak biofilm (MP and WP, respectively) or did not produce 
any biofilm (non-biofilm producer; NP). Regarding the biofilm-forming capacity (Fig. 
3.2), 61 (70.9%) clinical isolates were considered biofilm producers with the 
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following distribution: 9 (10.5%) isolates were strong producers, 11 (12.8%) were 
moderate producers and 41 (47.7%) were weak biofilm producers. Twenty-five 
(29.1%) isolates were considered non-biofilm producers and were equally 
distributed among the different age groups (p > 0.05).  
 
 
Figure 3.2: Distribution of biofilm formation capacity among the 86 Portuguese clinical isolates of S. 
epidermidis included in this study. 
 
S. epidermidis clinical isolates with a stronger biofilm-producing phenotype were 
more prevalent among patients older than 1 year old (88.8%, n = 8). No significant 
differences (p > 0.05) in biofilm formation were observed between the MRSE and 
MSSE isolates, indicating no significant correlation between methicillin/oxacillin 
susceptibility and the ability to form in vitro biofilms. When comparing the 
antimicrobial resistance to the ability to form biofilm (Table 3.5), fifty-three (71.6%) 
isolates with capacity to form biofilm appear to have a MDR phenotype (p > 0.05). 
Additionally, no association (p > 0.05) was found between MSSE and MRSE 
biofilm-forming isolates and MDR phenotype. Nevertheless, a strong association 
(p = 0.007) was found between MDR phenotype and the carriage of mecA gene. 
Interestingly, all (3.7%, n = 3) isolates susceptible to penicillin were also strong or 
moderated biofilm producers (p = 0.013) indicating that although showing great 
propensity to in vitro form biofilms, they were susceptible to one of the most used 
antibiotics worldwide. On the other side, the 3 isolates (3.5%) resistant to linezolid 
were poor biofilm formers (p > 0.05). Moreover, positive associations were also 
found between biofilm formation and some antibiotic susceptibility profiles such as, 
fusidic acid (p = 0.033) and gentamicin (p = 0.001).  
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Table 3.5: Relationship between antimicrobial non-susceptible profile and biofilm formation among 
S. epidermidis clinical isolates included in this study.  
Antibiotics 
Biofilm phenotype (%) 
SP  
(10.5%, n = 9) 
MP  
(12.8%, n = 11) 
WP  
(47.7%, n = 41) 
NP  
(29.1%, n = 25) 
Penicillin (n = 82) 77.8 81.8 97.6 92.0 
Erythromycin (n = 86) 66.7 81.8 78.0 84.0 
Fusidic acid (n = 86) 44.4 81.8 75.6 84.0 
Levofloxacin (n = 86) 44.4 54.5 78.0 76.0 
Gentamicin (n = 86) 11.1 72.7 78.0 76.0 
Tetracycline (n = 86) 66.7 100.0 61.0 72.0 
Clindamycin (n = 86) 33.3 63.6 58.5 64.0 
Trimethoprim-sulfamethoxazole (n = 85) 44.4 54.5 39.0 40.0 
Moxifloxacin (n = 86) 33.3 45.5 36.6 20.0 
Rifampin (n = 86) 44.0 45.0 29.0 24.0 
Teicoplanin (n = 86) 0.0 9.1 17.1 24.0 
Fosfomycin (n = 86) 0.0 0.0 12.2 0.0 
Linezolid (n = 85) 0.0 0.0 4.9 4.0 
Tigecycline (n = 86) 0.0 0.0 0.0 0.0 
Vancomycin (n = 86) 0.0 0.0 0.0 0.0 
Daptomycin (n = 67) 0.0 0.0 0.0 0.0 
Multidrug resistance (n = 86) 66.7 100.0 87.8 84.0 
Abbreviations: NP, non-biofilm producer; WP, week biofilm producer; MP; moderate biofilm producer; SP, strong biofilm producer. 
 
Furthermore, the relationship between biofilm formation and the carriage of icaA, 
aap and bhp biofilm-mediating genes was assessed (Fig. 3.3). Two sets of primers 
for each biofilm-associated gene were used, in order to minimize PCR 
amplification bias and false-negative results. The molecular determination of icaA, 
aap and bhp biofilm-mediating genes revealed that aap was the most prevalent 
gene, detected in 90.7% (n = 78) of the isolates, followed by icaA (64.0%, n = 55) 
and bhp (44.2%, n = 38). Regarding the association to biofilm phenotype, icaA and 
aap were more prevalent genes among isolates with strong and/or moderate 
biofilm-forming capacity, although aap seems more related to strong biofilm 
formation if in combination with the ica operon. Of interest, none of the clinical 
isolates was characterized by the presence of just bhp virulence-associated gene. 
Fifty-one out of 55 (92.7%) isolates were both icaA- and mecA-positive (p = 
0.041). Also, 70 out of 78 (89.7%) aap-positive and 37 out of 38 (97.4%) bhp-
positive isolates also carriage the mecA gene (p = 0.028 and p = 0.012, 
respectively). Additionally, the icaA gene was more common among MRSE biofilm 
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producers isolates (p = 0.006) while aap and bhp was rather more common among 
MRSE isolates with a weak or no in vitro biofilm-forming capacity (p > 0.05). 
Interestingly, the majority of the S. epidermidis isolates (83.7%, n = 72) were 
positive for at least 2 out of the 3 studied genes while only 4 (4.7%) isolates didn’t 
carried any gene and demonstrated a weak biofilm formation capacity. Moreover, 
the genetic combination most frequently observed was icaA+aap+ (39.5%, n = 34), 
followed by aap+bhp+ (22.1%, n = 19) and by the carriage of the 3-gene 
combination (icaA+aap+bhp+, 19.8%, n = 17). All clinical isolates that carriage the 
genetic combination icaA+aap+bhp+ (n = 17) were associated with both MRSE (p = 
0.001) and MDR phenotype (p = 0.001). Also, the majority of the isolates with the 
genetic combination aap+bhp+ demonstrated a methicillin-resistant and a MDR 
phenotype. 
 
 
Figure 3.3: Relationship between biofilm-associated genes and biofilm phenotype among S. 
epidermidis clinical isolates included in this study. 
 
 
3.4 Discussion 
Despite the highly prevalence of HAIs in Portugal (10.6 % in 2012) 10, limited 
information is available regarding those causing by coagulase-negative 
Staphylococci and biofilm-forming S. epidermidis in particular. In addition, Portugal 
has one of the highest rates of antimicrobial resistance and antibiotic consumption 
across the European Union 7. In the present study, we isolated 86 S. epidermidis 
clinical isolates and compared their phenotypic and molecular features with clinical 
data. The isolates were recovered from patients diagnosed with healthcare-
associated infections and receiving treatment at a tertiary-care teaching 
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Portuguese hospital with an average rate of HAIs incidence of 10.1%, during the 
time course of this study. To the best of our knowledge, this is the first study 
addressing biofilm formation and S. epidermidis antimicrobial resistance of clinical 
isolates in Portugal. A summary table (Table S3.A) concerning all the information of 
the 86 studied isolates is present at the end of this chapter. 
Bloodstream infections that included primary infections (i.e., those not related to a 
secondary site) and secondary infections (i.e., bacteremia associated with 
infection at another site) 280, were the most common type of infection among our 
study population which was not surprising, since S. epidermidis is the leading 
cause of bloodstream of infection episodes 7, 10, 11. The prevalence of patients 
receiving at least one antimicrobial agent was unexpectedly high (84.9%) 
comparatively to other countries in European Union (32.7% in overall facilities) 7 
and even to the reported national average (45.4%) 10. According to the 2013 
ECDC survey 7, the prevalence of antimicrobial use varied significantly among 
hospital types, the highest being observed in tertiary hospitals, which in part can 
explain the difference between the national (45.4%) and our local (83.7%) 
prevalence. It must be highlighted that the majority of these patients were already 
taking antibiotics for previously diagnosed infections. Additionally, these patients 
had several morbid conditions that, together with their age, suggest an 
immunocompromised status. Vancomycin alone or in combination, was the drug of 
choice, as recommended as a first line treatment for infections caused by 
methicillin-resistant Staphylococcal species 178.  
The rate of S. epidermidis isolates resistant to methicillin was high (87.2%), as 
compared to similar studies 285, 294, 295. Nevertheless, very high mecA prevalence 
has also been reported elsewhere 80, 286, 287, 296. Additionally, a molecular 
epidemiologic study conducted in the Portuguese capital revealed an MRSE rate 
similar to those obtained in our local tertiary-care hospital (79.8% versus 85.4%, 
respectively) 155, suggesting a spread transmission of methicillin-resistant S. 
epidermidis across major healthcare facilities of Portugal. This also suggests that 
this spread of resistance by resistance genes accumulation ie, mecA gene 
carriage, is mainly due to the selective pressure exerted by the use of antibiotics. 
Indeed, S. epidermidis in particular MRSE, isolates are considered reservoirs of, 
antimicrobial resistance genes and prone to accumulates these genes 297, which is 
a cause of major concern because of associated higher risk of therapeutic failure. 
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Importantly, and similarly to previous reported observations by Hellmark, et al. 295, 
the majority of S. epidermidis clinical isolates included in this study demonstrated 
resistance to at least 3 classes of antimicrobial agents groups tested, hence 
multidrug resistant. The MDR phenotype was statistically correlated (p = 0.001) to 
MRSE clinical isolates, suggesting that resistance might be due to either 
accumulation of resistance genes and to high antibiotic pressure associated with 
hospital care 278. Despite the high levels of resistance found in this hospital, our 
results are the expected for a device-related infection caused by S. epidermidis, as 
compared to other medical institutions.  
Furthermore, antimicrobial resistance is an innate feature of Staphylococcal 
biofilms that in addition, to the increasing rates of reported antimicrobial resistance 
amongst clinical isolates impairs patient treatment 278. As propensity for biofilm 
formation has an enormous clinical impact on drug resistance 34, 298, the in vitro 
biofilm forming capacity and the carriage of icaA, aap and bhp biofilm-associated 
genes of each clinical isolate was investigated. Similar to previously published 
studies 58, 93, 296, 299 the majority (70.9%) of our bacterial population exhibited in 
vitro biofilm-forming capacity, even if at different levels. The aap gene was the 
most commonly detected. However, S. epidermidis isolates that carried aap alone, 
demonstrated a diminished potential to in vitro form biofilms. These results 
indicated that this capacity may be enhanced by the presence of icaADBC genes 
although variable, as proposed by Stevens et al. 93. In addition, we found a 
positive association (p = 0.023) between biofilm phenotype and the presence of 
icaA biofilm-associated gene, a result consistent with those obtained by Hira et al. 
80. Taken together our results confirm that icaA is a key part of the biofilm process 
and owns major relevance in the pathogenesis of S. epidermidis as in fact 
demonstrated by many other studies 80, 93, 286. Regarding the role of bhp, we could 
not confirm any link to biofilm accumulation, also in accordance to other 
observation 58. 
Interestingly, the observed phenotypic features of these clinical isolates are in 
agreement with the data reported in a recent Portuguese study performed with 61 
community-acquired S. epidermidis isolates collected from healthy individuals from 
the same geographic region addressed in this study 300. These findings raise some 
concerns as they demonstrate that S. epidermidis isolates recovered from the 
Portuguese community share a similar antibiotic resistance pattern and biofilm 
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formation ability to those recovered from the clinical setting. Together, these 
results point out that adequate antibiotic prescription is a growing necessity in 
order to minimize the antimicrobial resistance and clinical impact of S. epidermidis 
outside or inside of the healthcare institutions. Nevertheless, it should me 
mentioned that in both studies a limited number of isolates was studied. In the 
future, this limitation should be addressed to reach a more comprehensive 
understanding of healthcare infections associated to S. epidermidis, in Portugal.  
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Table S3.A: Phenotypic and molecular features of the 86 S. epidermidis isolates recovered from patients with a diagnosis of device-related infection. 
Phenotypic and molecular information 
Isolates 
Biofilm-forming 
capacity 
Biofilm-mediating 
genes 
mecA 
detection 
Non-susceptible profile 
PT11001 SP icaA+; aap+; bhp- + PEN; FA; RIF; 
PT11002 WP icaA-; aap-; bhp- nd PEN; CLI; ERY; FA; GEN; LVX; SXT; 
PT11003 MP icaA+; aap+; bhp- + PEN; CLI; ERY; LVX; MXF; RIF; TET; SXT; 
PT11004 NP icaA+; aap+; bhp- + PEN; ERY; RIF; TET; SXT; 
PT11005 WP icaA-; aap+; bhp- nd PEN; ERY; FOF; SXT; 
PT11006 SP icaA+; aap-; bhp- + PEN; LVX; TET; SXT; 
PT11007 MP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; TET; 
PT11008 NP icaA+; aap+; bhp- + PEN; CLI; FA; GEN; LVX; MXF; TET; SXT; 
PT11010 WP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; MXF; RIF; TET; 
PT11011 MP icaA+; aap+; bhp+ + CLI; ERY; FA; GEN; TET; 
PT11012 MP icaA-; aap+; bhp+ + PEN; FA; GEN; LVX; TET; TEC; 
PT11013 NP icaA+; aap+; bhp- + PEN; CLI; FA; GEN; LVX; MXF; LZD; TET; TEC; SXT; 
PT11014 NP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; 
PT11015 NP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; 
PT11016 WP icaA+; aap-; bhp+ + PEN; FA; GEN; LVX; RIF; 
PT11018 WP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; LVX; MXF; RIF; TET; SXT; 
PT11019 NP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; 
PT12003 SP icaA+; aap-; bhp+ + PEN; RIF; 
PT12004 MP icaA-; aap+; bhp- nd PEN; ERY; FA; RIF; TET; SXT; 
PT12005 WP icaA-; aap+; bhp- + PEN; FA; LVX; MXF; 
PT12007 WP icaA+; aap+; bhp- + PEN; ERY; 
PT12008 NP icaA+; aap+; bhp- nd PEN; ERY; FA; GEN; TET; 
PT12009 WP icaA+; aap+; bhp+ + PEN; FA; GEN; LVX; MXF; TET; 
PT12010 WP icaA-; aap+; bhp+ + PEN; FA; GEN; LVX; SXT; 
PT12013 SP icaA+; aap+; bhp- + PEN; ERY; TET; SXT; 
PT12015 WP icaA-; aap+; bhp+ + PEN; ERY; FA; GEN; LVX; MXF; TET; TEC; SXT; 
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PT12016 WP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; LVX; MXF; LZD; TET; TEC; SXT; 
PT12019 MP icaA+; aap+; bhp- + CLI; ERY; FA; GEN; LVX; MXF; RIF; TET; SXT; 
PT12020 WP icaA+; aap+; bhp+ + PEN; CLI; ERY; LVX; 
PT12023 MP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; LVX; MXF; RIF; TET; 
PT12025 SP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; RIF; TET; 
PT12026 NP icaA-; aap+; bhp- nd PEN; CLI; ERY; LVX; MXF; RIF; TET; 
PT12027 WP icaA-; aap-; bhp- + PEN; FA; RIF; 
PT12028 WP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; RIF; 
PT12031 WP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; 
PT12033 WP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; 
PT12034 WP icaA+; aap+; bhp+ + PEN; ERY; FA; GEN; LVX; RIF; TEC; SXT; 
PT12035 MP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; TET; SXT; 
PT12037 WP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; SXT; 
PT12039 WP icaA+; aap+; bhp- + CLI; ERY; FA; FOF; GEN; LXV; MXF; TET; SXT; 
PT12040 NP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; SXT; 
PT12042 NP icaA-; aap+; bhp- + PEN; ERY; FA; RIF; TET; 
PT12043 SP icaA+; aap+; bhp- + PEN; CLI; ERY; LVX; MXF; RIF; TET; 
PT12044 NP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; SXT; 
PT12045 WP icaA-; aap-; bhp- + PEN; FA; FOF; GEN; TET; 
PT12047 NP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; 
PT12048 WP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; 
PT12050 WP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; LVX; MXF; RIF; TET; 
PT12052 WP icaA-; aap+; bhp- nd PEN; GEN; TET; 
PT12053 NP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; 
PT12054 NP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; TEC; 
PT12055 WP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; LVX; MXF; RIF; TET; SXT; 
PT12057 WP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; 
PT12060 WP icaA-; aap+; bhp+ nd PEN; ERY; 
PT12062 NP icaA+; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; SXT; 
PT12063 NP icaA+; aap-; bhp- nd PEN; ERY; FA; SXT; 
PT12065 NP icaA-; aap+; bhp+ + PEN; LVX; TEC; 
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PT12066 MP icaA+; aap+; bhp- nd PEN; FA; GEN; LVX; MXF; RIF; TET; 
PT13001 WP icaA+; aap+; bhp- + PEN; CLI; ERY; GEN; LVX; TET; 
PT13004 WP icaA+; aap+; bhp- + PEN; GEN; LXV; MXF; TEC; SXT; 
PT13005 WP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; FOF; GEN; LXV; MXF; TET; 
PT13007 WP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; TEC; 
PT13008 NP icaA-; aap+; bhp+ + PEN; ERY; FA; GEN; LVX; TEC; 
PT13012 WP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; TEC; 
PT13013 WP icaA+; aap+; bhp- + CLI; ERY; GEN; LVX; MXF; TET; 
PT13014 NP icaA-; aap+; bhp- + PEN; CLI; ERY; FA; GEN; TET; 
PT13016 WP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; SXT; 
PT13018 WP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; FOF; GEN; LXV; MXF; LZD; RIF; TET; TEC; 
PT13019 WP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; TET; SXT; 
PT13021 WP icaA-; aap-; bhp- nd PEN; ERY; FA; GEN; TET; 
PT13022 WP icaA-; aap+; bhp+ + PEN 
PT13023 SP icaA+; aap+; bhp- + PEN; ERY; FA; LVX; MXF; TET; SXT; 
PT13024 WP icaA-; aap+; bhp+ + PEN; FA; GEN; LVX; TET; SXT; 
PT13025 NP icaA+; aap+; bhp- + CLI; ERY; GEN; LVX; MXF; TET; TEC; SXT; 
PT13026 MP icaA+; aap+; bhp- + PEN; ERY; LVX; MXF; TET; SXT; 
PT13028 WP icaA+; aap+; bhp- + PEN; ERY; LVX; MXF; TET; SXT; 
PT13029 MP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; GEN; TET; SXT; 
PT13031 SP icaA+; aap+; bhp- nd PEN; ERY; 
PT13032 SP icaA+; aap+; bhp- + PEN; CLI; ERY; FA; LVX; MXF; TET; SXT; 
PT13033 NP icaA-; aap+; bhp+ + PEN; ERY; FA; GEN; LVX; RIF; TET; SXT; 
PT13034 WP icaA-; aap+; bhp+ + ERY; FA; GEN; LVX; TET; SXT; 
PT13037 NP icaA-; aap+; bhp- + FA; TET; SXT; 
PT13039 WP icaA+; aap+; bhp- + PEN; ERY; FA; LVX; MXF; TET; 
PT13040 NP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; GEN; LVX; TET; 
PT13041 NP icaA-; aap+; bhp+ + PEN; CLI; ERY; FA; LXV; TEC; 
PT13042 NP icaA+; aap+; bhp- + PEN; CLI; ERY; GEN; LVX; MXF; TET; 
Abbreviations: NP, non-biofilm producer; WP, week biofilm producer; MP; moderate biofilm producer; SP, strong biofilm producer; -, PCR negative; +, PCR positive; nd; not 
detected; PEN; Penicillin; CLI, Cindamycin; ERY, Erythromycin; FA, Fusidic Acid; FOF, Fosfomycin; GEN, Gentamicin;  LZD, Linezolid; LVX, Levofloxacin; RIF, Rifampin; MXF, 
Moxifloxacin; TET, Tetracycline; SXT, Trimethoprim/sulfamethoxazole; Underlying antibiotics demostrated an intermediary phenotype. 
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CHAPTER 4 
 
 
 
 
RELATIONSHIP BETWEEN ICAA, AAP AND 
BHP GENES EXPRESSION AND BIOFILM 
DEVELOPMENT OF CLINICAL AND 
COMMENSAL S. EPIDERMIDIS ISOLATES 
This chapter provides a better understanding of the interactions between 
biofilm-mediating icaA, aap and bhp genes in clinical and commensal S. 
epidermidis isolates, and their contribution to the process of biofilm formation.  
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4.1 Introduction 
Colonization and development of biofilms on host tissues or indwelling medical 
devices is currently a major healthcare problem that is closely tied to the 
pathogenesis of this bacterium as it increases resistance to multiple classes of 
antibiotics 301, 302 and host immune defenses 202, 210.  
The physiology of biofilm development appears to be complex and 
multifactorial, and bacterial colonization is considered the primary mechanism of 
S. epidermidis pathogenesis 32. Once attached to the substrata, S. epidermidis 
cells proliferate, eventually becoming enmeshed within an extracellular 
polymeric substance (EPS) due to self-secretion of biomolecules, and then 
accumulate as multilayered cell clusters 29, 33. A biofilm is thus defined as a 
structured aggregation of bacteria enclosed in a matrix consisting of a mixture 
of macromolecules such as polysaccharides, proteins and extracellular DNA 
that together protects biofilm bacteria from environmental stresses 31-33. Poly-N-
acetyl-glucosamine (PNAG), also designated polysaccharide intercellular 
adhesin (PIA), is synthesized by proteins encoded in the icaADBC locus 61, 62, 78 
and has been for long identified as a major molecule involved in biofilm 
formation 69, 264. Additionally, PIA has a significant function in the protection of 
S. epidermidis biofilm cells from host innate defenses 210 and significantly 
affects the tridimensional (3D) structure of mature biofilms 303. Despite the role 
of PIA in biofilm formation, PIA-independent mechanisms that rely on protein-
protein interactions have been described in this process 58, 135, 304. The cell wall 
accumulation-associated protein (Aap) 44, 84, 305 and the homologue to the 
biofilm-associated protein (Bap) of S. aureus protein (Bhp) 86, 89-91, are the best 
characterized determinants involved in protein-mediated biofilm formation 
mechanisms. Therefore, many in vitro and in vivo studies highlighted the 
substantial role of PIA, Aap and Bhp molecules in the adhesion and 
accumulation stages of biofilm formation 45, 90, 290. Despite their importance, 
molecular studies are often performed with wild-type and respective mutant 
strains. Thus, the impact of these genes in clinical isolates has not yet been 
properly studied. Moreover, it remains to be elucidated how icaA, aap and bhp 
genes may contribute to the development of biofilms by clinical isolates over 
time. In order to better understand the pathophysiology of S. epidermidis 
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infections, this study aims to analyze the interactions between biofilm-mediating 
icaA, aap and bhp genes in clinical and commensal S. epidermidis isolates, and 
their contribution to the process of biofilm formation, and thus, infer about S. 
epidermidis pathogenesis. For this purpose, a total of 19 S. epidermidis clinical 
and community isolates, were characterized regarding their ability to form 
biofilm, gene expression profile, matrix composition and their biofilm 3D 
structure. 
 
 
4.2 Materials and Methods 
S. epidermidis bacterial isolates 
Twelve S. epidermidis clinical isolates recovered from patients with infected 
implanted devices (characterized in chapter 3) and seven commensal isolates 
recovered from randomly selected healthy individuals, non-workers of 
healthcare facilities 300, were selected from our collection. Each genetic group 
was defined according to the presence or absence of biofilm-mediating genes 
icaA, bhp and aap (Table 4.1). Three distinct S. epidermidis isolates (2 from the 
clinical setting and 1 community-acquired, whenever possible) were included 
per group, with the exception of those carrying a bhp+ or icaA+ genotype alone, 
which comprise only 2 isolates due to the inexistence of others carrying the 
same genetic trait in both collections. Additionally, all 19 isolates included in this 
study were previously characterized in regard to their antimicrobial resistance 
profile 300 and genetic similarities between those isolates were accessed by 
rpoB sequencing (Fig. 4.1). The DNA sequencing analysis was performed by the 
Eurofins MWG Operon Company (http://www.eurofinsgenomics.eu) using the 
ABI 3730XL sequencing machine.  
In brief, polymerase chain reaction (PCR) was performed directly from bacterial 
gDNA obtained by the rapid DNA extraction method (as described in chapter 3) 
in a final volume of 60 μL. Four μL of extracted DNA were used as a template 
and added to 56 μL of PCR mix containing 30 μL of DyNAzyme II PCR Master 
Mix 2x (Finnenzymes), 4 μL of primer mixture with a concentration of 10 μM 
(Table 4.2) and 22 μL of nuclease-free water. For the detection of rpoB (899 bp), 
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the forward and reverse primers had the following sequences: 5′ – 
CAATTCATGGACCAAGC – 3’ and 5′ – CCGTCCCATGTCATGAAAC – 3’, respectively. 
The PCR reaction was performed using the MJ Mini thermal cycler (Bio-Rad) 
beginning with an initial denaturation step at 94 °C for 5 min followed by 35 
cycles of 94 °C for 45 sec, 60 °C for 60 sec, and 72 °C for 90 sec, ending with a 
final extension step at 72 °C for 10 min and followed by a hold at 4 °C. Then, 
amplified products were analyzed in 1% agarose gel stained with Midori Green 
DNA stain (Nippon Genetics Europe GmbH). The PCR product was then 
purified using GRS PCR & Gel Band Purification Kit (GRiSP) and gDNA was 
quantified with a Nanodrop 1000TM (Thermo Scientific), following the Eurofins 
MWG Operon Company requirements to sample submission. The nucleotide 
sequences of each isolate were analyzed using the Basic Local Alignment 
Search Tool (http://blast.ncbi.nlm.nih.gov/blast.cgi).  
 
Table 4.1: Distribution of the selected S. epidermidis isolates according to their genetic trait. 
S. epidermidis isolates Origin Genotype profile a 
PT12006 Chapter 3 
icaA
+
aap
+
bhp
+
 PT12020 Chapter 3 
SECOM030A 
300
 
PT11006 Chapter 3 
icaA
+
 
SECOM049A 
300
 
PT11003 Chapter 3 
icaA
+
aap
+
 PT12013 Chapter 3 
SECOM004A 
300
 
PT11016 Chapter 3 
icaA
+
bhp
+
 PT12003 Chapter 3 
SECOM020A1 
300
 
PT11012 Chapter 3 
aap
+
bhp
+
 PT12010 Chapter 3 
PT12015 Chapter 3 
SECOM040A 
300
 
bhp
+
 
SECOM042A 
300
 
PT12004 Chapter 3 
aap
+
 PT12005 Chapter 3 
SECOM023A 
300
 
a 
The methods are described in chapter 3 
 
Furthermore, the phenogram was constructed based on rpoB sequences data. 
The nucleotide sequences were first aligned and then the phenogram was 
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generated with the neighbor-joining algorithm by using the CLC Sequencer 
Viewer 7.6. The tree was resampled with 1000 bootstrap replications to ensure 
the robustness of the data. 
 
Figure 4.1: Neighbor-joining tree based on the rpoB gene sequences showing the phylogenetic 
relationships among the S. epidermidis isolates selected for this study. The value on each branch 
node is the bootstrap value (%) and the scale bar represents 0.011 changes per amino acid position. 
 
In vitro biofilm formation 
Biofilm cultures of each S. epidermidis isolate were performed as described in 
the previous chapters with minor modifications. Briefly, a starter culture was 
grown overnight in Tryptic Soy Broth (TSB, Liofilchem) at 37 °C and orbital 
shaking at 80 rpm (20 mm orbit diameter, Celltron, INFORS HT). Two or 10 μL 
of the starter culture were inoculated into 200 μL or 1 mL of TSB supplemented 
with 0.4% (w/v) of glucose to induce biofilm formation, in 96- or 24-well 
polystyrene plates (Orange Scientific), respectively. Biofilm cultures of 12, 24, 
54 or 72 h, were growing in the same conditions as the starter cultures. After 
each 24 h, the growth medium was carefully discarded and replaced by fresh 
one. 
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Semi-quantitative biofilm assay 
After 24 and 72 h of in vitro biofilm formation in 96-well polystyrene plates, the 
total biomass was assessed through a semi quantitative assay previously 
described and detailed in chapter 3. At least three independent experiments with 
16 replicates each, were performed and similar results were obtained. The 
biofilm-forming and icaA-, aap- and bhp-positive S. epidermidis strain 9142 was 
used as reference strain. 
 
Biofilm matrix disruption assay 
Sodium meta-periodate (NaIO4) and proteinase K which target biofilm matrix 
components as glucose-containing polysaccharides and proteins respectively, 
were tested for their ability to disrupt preformed S. epidermidis biofilms from 
polystyrene plate wells. Biofilm matrix disruption assays were performed as 
previously described 306, 307. Briefly, biofilms were grown in the 96-well 
polystyrene plates for 72 h followed the same conditions as described above. 
After each biofilm formation period, the media and non-adherent cells were 
removed and the adherent biofilm was washed gently in 200 μL of sterile water. 
Then, 200 μL of 40 mM NaIO4 (Sigma-Aldrich) in water or 0.1 mg/mL proteinase 
K (Sigma-Aldrich) in 20 mM Tris-HCl (pH 7.5) and 1 mM CaCl2, were carefully 
added to minimize mechanical detachment of biofilms. Control wells received 
an equal volume of buffer without enzyme. Plates were incubated for an extra 2 
h at 37 ºC, and following incubation the content of each well was discarded and 
washed twice with sterile water. Then, crystal violet quantification was 
performed as detailed in chapter 3 to quantify the amount of stained biofilm 
remaining after each treatment, relative to that after treatment with the control 
reagent (buffer). Three independent experiments with 9 replicates for each 
treatment conditions were performed and similar results were obtained. S. 
epidermidis strain 9142 was used as reference strain. 
 
Gene expression quantification 
RNA extraction and cDNA synthesis:  RNA extraction from 12 and 54 h-old biofilms 
grown on 24-well polystyrene plates, was performed following a previously 
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optimized protocol 308, as detailed in chapter 2. Briefly, the optimized protocol 
combines both chemical and mechanical lysis together with a column system 
for RNA isolation (E.Z.N.A® Total RNA kit I, Omega Bio-Tek®). After RNA 
extraction, gDNA was digested with DNase I (Thermo Scientific) following the 
manufacturer’s instructions. The total RNA was quantified with a Nanodrop 
1000TM (Thermo Scientific) and reverse transcribed in complementary DNA 
(cDNA), using the enzyme RevertAidTM H minus reverse transcriptase (Thermo 
Scientific) as described elsewhere 308. The RNA integrity was assessed by 
agarose gel electrophoresis and visualized using a ChemiDocTM XRS (Bio-
Rad). In order to determine contamination by gDNA, a control lacking the 
reverse transcriptase enzyme (no-RT control) was prepared per sample. The 
RNA extraction and the subsequent cDNA synthesis of each biofilm with 
different ages of maturation per isolate were performed in triplicate. 
 
Table 4.2: Oligonucleotide sequence used in the qPCR run. 
Gene Oligonucleotide sequence (5’ to 3’) TM (°C) 
PCR product 
size (bp) 
Primer 
efficiency (%) 
16S 
FW: GGG CTA CAC ACG TGC TAC AA 59.79 
176 92.5 
RV: GTA CAA GAC CCG GGA ACG TA 59.85 
icaA 
Fw: TGC ACT CAA TGA GGG AAT CA 60.20 
134 89.4 
Rv: TAA CTG CGC CTA ATT TTG GAT T 59.99 
aap 
Fw: GCA CCA GCT GTT GTT GTA CC 59.22 
190 93.9 
Rv: GCA TGC CTG CTG ATA GTT CA 59.98 
bhp 
Fw: TGG ACT CGT AGC TTC GTC CT 60.01 
213 95.0 
Rv: TCT GCA GAT ACC CAG ACA ACC 60.13 
 
Quantitative RT-PCR run: The qPCR reaction using the obtained mRNA as 
template was previously described 308 as detailed in chapter 2. The qPCR 
specific for icaA, aap and bhp were performed using iQTM SYBR® Green 
supermix (Bio-Rad) with an CFX96TM Thermal cycler (Bio-Rad) setup for an 
initial denaturation of 10 min at 94 °C followed by 40 repeats of 5 sec at 94 °C, 
10 sec at 60 °C and 15 sec at 72 °C. In addition, 16S rRNA gene that encodes 
the small subunit of the ribosome was used as reference gene. A mock qPCR 
reaction lacking the cDNA template was prepared and used as no-template 
control. The quantification of the mRNA transcripts, for each gene under study, 
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was determined using the delta Ct method (EΔCt), a variation of the Livak 
method 309. Primers used in the RT-PCR are described in table 4.2. 
 
Biofilm 3D structure analysis by confocal laser scan microscopy 
Biofilms of selected S. epidermidis isolates were grown up to 72 h in 8-well 
Chamber Slide (Lab-Tek II; Nalge Nunc International) as described above with 
minor modifications. Briefly, 300 µL aliquots were added to chamber wells and 
incubated for 72 h at 37 ºC under agitation as mentioned above. Medium was 
carefully removed from wells and biofilms were rinsed with 300 µL of sterile 
water and stained for fluorescent confocal scanning laser microscopy (CSLM, 
OLYMPUS FLUOVIEW 1000) analysis. Biofilms were incubated in the dark for 
15 min with 100 µL containing 0.01 mg/mL wheat germ agglutinin (WGA)-
TRITC conjugate (Molecular Probes) that stains PIA molecules. Cells were 
stained with 100 µL of 5 µM SYTO® BC nucleic acid stain (Molecular Probes). 
Extracellular proteins were visualized by incubation in the dark for 30 min with 
100 µL undiluted of SYPRO Ruby biofilm matrix (Molecular Probes). Stains 
were removed, and wells were rinsed with sterile water between each stain and 
before imaging. Each experiment was performed twice with technical 
duplicates. 
 
Biofilm matrix composition 
Extracellular biofilm matrix was collected from biofilms of selected S. 
epidermidis isolates grown in 24-well polystyrene plates for 72 h. Briefly, 
biofilms were scraped off, sonicated using a protocol previously optimized 310, 
and then centrifuged at 6000 rpm for 10 min at 4 ºC to separate biofilm cells 
from soluble matrix material. The soluble matrix material was then filtered using 
a 0.2 μm pore size filter to eliminate the intact biofilm cells and then lyophilized 
for further use. Proteins were determined by using the bicinchoninic acid (BCA) 
assay (Pierce Biotechnology) following manufactures’ instructions and 
polysaccharides were estimated according to the procedure described by 
Dubois et al. 311, using glucose as a standard. The colorimetric experiments 
were performed 3 to 5 times independently per each biofilm growth period, with 
3 replicates at a time. The results were expressed in μg per mL of biofilm. 
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Additionally, the S. epidermidis strain 9142 was used as a positive reference 
strain.  
 
Statistical analysis 
Statistical evaluations were performed with the GraphPad Prism software 
version 6.04 by using Student’s t-test for the comparison of two groups. A 
confidence level of ≥ 95% was considered statistically significant. 
 
 
4.3 Results 
Biofilm formation and disruption evaluation 
Based on the previously established criteria, 19 isolates from different origins 
and showing different phylogenetic relationships (Fig. 4.1) were selected in order 
to assess the genetic contribution of icaA, aap and bhp in biofilm formation by 
clinical and commensal isolates of S. epidermidis. For this purpose, all strains 
were incubated up to 72 h and in vitro biofilm-formation was assessed. 
As illustrated in figure 4.2, the isolates carrying the icaA gene were more prone 
to form larger amounts of biofilm and this was more evident at older biofilms (72 
h-old). In fact, all isolates, with the exception of PT12015, had increased their 
biofilm biomass over time and some (31.6%, n = 6) were as strong biofilm 
producers as the reference strain 9142. No differences were found in the 
degree of biofilm formation between isolates that carry icaA alone or in 
combination with aap and/or bhp. Furthermore, S. epidermidis isolates that do 
not carry the ica operon displayed less capacity to form biofilm when compared 
to icaA+ isolates.  
A few studies have referred that the proportion of polysaccharides and proteins 
in the biofilm matrix greatly varies among different strains and it is dependent on 
the growth conditions 312. In order to better understand those differences and 
the nature of the molecules involved in the biofilm structure, we have tested the 
sensitivity of 72 h-old biofilms to NaIO4 and proteinase K – two biofilm 
degrading agents (Fig. 4.3). Polysaccharides undergo oxidation by NaIO4 
313, 
while proteins were targeted and digested by proteinase K 314. 
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Figure 4.2: Characterization of biofilm formation by S. epidermidis clinical and commensal 
isolates during 24 and 72 h of growth. Bars correspond to average values of measurements taken from 
16 duplicate wells of at least 3 independent assays and error bars represent the standard deviations. 
Statistically significant differences observed between biofilms grown for 24 and 72 h are indicated by the 
asterisks (*). The S. epidermidis 9142 was used as a reference strain. 
 
As expected, preformed biofilms of strain 9142 were efficiently dispersed by 
NaIO4 while it remained nearly intact after proteinase K digestion 
315. A similar 
effect was found on icaA+aap+bhp+ biofilms. Not surprising, biofilms from the 
isolates belonging to the aap+ group were partially digested by proteinase K 
although not sensitive to the action of NaIO4. Furthermore, similar effect was 
expected in bhp+ and aap+bhp+ groups. 
Regarding icaA+ S. epidermidis isolates, we have found overall an increased 
effect of NaIO4 in biofilm disruption, as expected. In addition, S. epidermidis 
strains with higher sensitivity to NaIO4 were those showing thicker biofilms by 
72 h of growth. There were, however, some exceptions. For instance, despite 
the presence of icaA gene, NaIO4 had little effect on the disruption of the biofilm 
of SECOM049A (icaA+), SECOM004A (icaA+aap+) and PT11016 (icaA+bhp+) 
isolates. Interestingly those strains did not form thick biofilms suggesting a 
lower content in polysaccharides.  
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Figure 4.3: Effects of NaIO4 and proteinase K on pre-formed 72 h-old biofilms of S. epidermidis 
clinical and commensal isolates. Bars are the mean averages of 3 independent experiments with 9 
replicates and the error bars represent the standard deviations. The percentage of biofilm reduction was 
calculated according to the following formula: 1 - (Abs buffer plus enzyme / Abs buffer alone) x 100. The S. epidermidis 
9142 was used as a reference strain. 
 
The effect of icaA, aap and bhp expression in S. epidermidis isolates biofilm 
formation  
While many studies have related biofilm formation to the presence of known 
biofilm-associated genes, fewer studies have studied the expression of those 
genes and its consequence in biofilm accumulation. In order to assess the 
relative contributions of icaA, aap and bhp expression in biofilm accumulation, 
RNA was extracted in earlier (12 h) and later (54 h) stages of biofilm formation 
and specific gene expression was assessed by qPCR. The expression levels of 
icaA, aap and bhp biofilm-mediating genes are presented in table 4.3. By 
normalizing gene expression to that of reference 16S rRNA gene, we were able 
to quantify the relative expression of each assessed gene. An interesting overall 
observation was that within each isolate, we found gene expression variability 
up to 500 fold (bhp was expressed 499 fold higher than aap, in PT12015 at 54 
h), independently of the condition tested. Also independently of the genetic 
background, isolates with higher biomass and with a higher increase in biomass 
over time were the ones with the highest increase in icaA expression from 12 to 
54 h of growth. Such an example is observed in the ~23-fold increase in icaA 
expression (6.76±2.52E-05 at 12 h versus 1.58±0.39E-03 at 54 h) observed in  
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Table 4.3: Gene expression analysis in 12 h- and 54 h-old biofilms of clinical and commensal isolates of S. epidermidis. 
Gene status 
group 
S. epidermidis 
isolates 
mRNA expression normalized to 16S RNA   
bhp aap icaA 
12 h 54 h p-value* 12 h 54 h p-value* 12 h 54 h p-value* 
icaA+aap+bhp+ 
PT12006 1.61±0.56E-05 2.52±0.91E-05 0.002 1.35±0.43E-04 1.71±0.30E-04 0.047 2.12±1,22E-06 1.01±0.86E-05 0.003 
PT12020 2.34±1.13E-05 2.61±1.53E-05 > 0.05  1.27±0,50E-04 1,55±0.94E-04 > 0.05  2.75±2,11E-06 1.20±0.44E-06 > 0.05  
SECOM030A 2.98±1.73E-05 1.95±0.78E-05 > 0.05  1.72±0.51E-04 4.31±1.12E-04 < 0.0001 3.17±1.56E-05 1.50±0.80E-04 0.002 
icaA+ 
PT11006   
 
    
 
  3.47±1.86E-05 6.91±2.46E-05 0.013 
SECOM049A   
 
    
 
  1.75±0.80E-05 3.00±0.87E-05 0.002 
icaA+aap+ 
PT11003       1.89±0.81E-05 7,05±0,60E-05 < 0.0001 6.76±2.52E-05 1.58±0.39E-03 < 0.0001 
PT12013   
 
  3.00±1.33E-05 7,67±5,76E-05 0.044 2.83±0.13E-05 5.16±0.61E-05 < 0.0001 
SECOM004A       1.77±1.29E-05 2.75±1.65E-05 0.006 6.07±5.68E-07 1.28±1.23E-06 > 0.05  
icaA+bhp+ 
PT11016 1.02±0.86E-06 1.30±1.13E-05 0.003       9.50±0.10E-08 3.57±2.44E-07 0.011 
PT12003 2.82±1.39E-06 6.51±2.58E-06 0.001   
   1,08±0.54E-04 3.93±2.56E-04 0.002 
SECOM020A1 3.20±1.61E-05 5.07±4.23E-05 > 0.05        4.70±2.32E-05 1.98±2.55E-04 0.045 
aap+bhp+ 
PT11012 2.22±0.63E-06 2.82±1.71E-05 0.002 9.14±2.28E-06 5.01±3.74E-05 0.003       
PT12010 4.78±2.81E-06 2.87±1.08E-05 0.001 3.68±1.72E-07 1.69±1.08E-05 0.011   
 
  
PT12015 3.61±1.40E-06 1.02±0.11E-04 < 0,0001 2.18±1.06E-07 2.05±1.30E-07 > 0.05        
bhp+ 
SECOM040A 6.03±0.67E-06 1.49±0.56E-05 0.003   
 
    
 
  
SECOM042A 1.02±0.86E-06 1.78±0.95E-06 > 0.05              
aap+ 
PT12004       3.84±2.78E-05 2.15±0.84E-04 < 0.0001       
PT12005   
 
  1.78±0.93E-05 2.76±1.17E-05 0.048   
 
  
SECOM023A       2.56±1.43E-05 3.08±0.60E-05 > 0.05        
*p < 0.05 by Student’s t-test was used for the comparison of the levels of gene expression between 12 and 54 h-old biofilms. 
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PT11003 isolate and the respective increase in biofilm observed. Amongst these 
isolates, PT12015 showed the less extent of biofilm formation and this associated 
with a significantly lower expression of aap, especially at 54 h. Interestingly, a ~28-
fold increase in bhp expression between 12 and 54 h was observed, but no 
increase in biomass was detected.  
 
Biofilm 3D structure and matrix composition 
Based on the previous results, we became interested in further exploring the 
phenotype of a few isolates. For this purpose, PT11006 (icaA+), PT12004 (aap+), 
SECOM040A (bhp+) and PT11003, PT12013 (icaA+aap+) and, PT12003 and 
SECOM020A1 (icaA+bhp+) isolates were visualized by CLSM (Fig. 4.4) and the 
amount of proteins and polysaccharides was quantified. 
Confirming our previous gene expression determinations, biofilm accumulation 
and detachment data, CLSM imaging confirmed that SECOM040A (bhp+) and 
PT12004 (aap+) exhibit a flat 3D biofilm structure, harboring lower biomass than 
PT11006 (icaA+). Conversely, the icaA+ isolate exhibited the typical “mushroom” 
structure which is highly associated with ica-mediated biofilm growth. Furthermore, 
we detected 19±4 g of proteins in the matrix per mL of biofilm in PT11006 clinical 
isolate, while both SECOM040A and PT12004 only had 11±3 g/mL and 13±3 
g/mL, respectively. This is not surprising since the total biomass of PT11006 was 
higher comparatively to icaA- isolates, and many more proteins can be found in the 
matrix than Aap or Bhp. The analysis of the icaA+aap+ group also confirmed our 
previous observations, having PT11003 a higher cell density and polysaccharide-
content than PT12013. The higher concentration of polysaccharides was also 
confirmed by the Dubois quantification (28±11 g/mL in PT11003 versus 5±2 
g/mL in PT12013). Interestingly, the concentration of proteins in the matrix was 
more similar (16±4 g/mL in PT11003 versus 19±7 g/mL in PT12013). Despite 
the different origins, the PT12003 clinical isolate and SECOM020A1 commensal 
isolate – both belonging to the icaA+bhp+ group, exhibited a very similar biofilm 
structure. Nevertheless, while the polysaccharide concentration was similar in both 
biofilms (7±3 and 7±4 g/mL, respectively), PT12003 had a significant higher 
protein content in the matrix (56±7 g/mL versus 19±8 g/mL). Interestingly, 
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overall CLSM analysis revealed that polysaccharides usually accumulate in 
clusters while proteins appear to be more evenly distributed through the biofilm. 
 
 
Figure 4.4: CLSM observation of 72 h-old biofilms formed by isolates of S. epidermidis. Triple 
staining was done with SYTO® BC for nucleic acids, WGA-TRITC that stains the extracellular PIA and with SYPRO® 
Ruby that stain the proteinaceous content. The last picture is the merged image of the three channels. 
Magnification of ×400. 
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4.4 Discussion 
Understanding how specific virulence-associated genes individually influence the 
biofilm accumulation and proliferation in clinical and/or commensal isolates, is of 
upmost importance. Independent reports have shown that biofilm formation by S. 
epidermidis is influenced by different molecular mechanisms. Furthermore, in vitro 
quantification of the biofilm proliferation, the transcriptional analysis of the genes 
that mediate this biofilm formation and the estimation of the biochemical 
composition of the biofilm matrix of S. epidermidis isolates, will improve the 
understanding of the phenotypic variations that might led to the in vivo adaption of 
S. epidermidis isolates. With this in mind, we selected 19 S. epidermidis isolates 
according to their genetic trait and then studied the relationship between icaA, aap 
and bhp transcription and the biofilm phenotype exhibited by clinical and 
commensal isolates grown over time and at the same in vitro conditions.  
Overall our results have shown that icaA+ isolates were unquestionably the 
stronger biofilm producers, independently of the time of growth tested (up to 72 h). 
Nevertheless, it is still important to understand how this growth ie, biofilm 
development, is related to the expression of specific genes and to the composition 
of extracellular matrix. As biofilm regulation is a cascade of cross-linked events 
working together to maintain the biofilm structure, it is conceivable that bacterial 
isolates with a different genetic pattern could display similar phenotypes. In order 
to infer about the biochemical composition of the biofilm matrix of each individual 
isolate, we have investigated the susceptibility of pre-formed 72 h aged biofilms to 
two biofilm-degrading agents (NaIO4 and proteinase K). As expected, 
proteinaceous biofilms were digested by proteinase K while S. epidermidis ica-
dependent biofilm were highly sensitive to NaIO4 therefore demonstrated the 
importance of polysaccharides in those biofilms.  
Aiming at further understanding the impact of biofilm-related gene expression on 
the phenotypic variations observed between S. epidermidis isolates, we had 
quantified the in vitro expression of icaA, aap and bhp genes in 12 h- and 54 h-old 
biofilms. Ours results showed that the isolates with higher icaA expression also 
formed larger amounts of biofilm which was not surprising, since most well 
described S. epidermidis strains considered stronger biofilm producers, carry the 
icaADBC operon. While icaA gene expression was more pronounced at 54 h (with 
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the exception of the PT12020 isolate) aap was the most expressed gene at earlier 
and later stages of biofilm growth within icaA+aap+bhp+ group. Interestingly, the 
higher aap expression do not correlated to a higher biofilm formation. However, it 
has been suggested that, during in vitro biofilm accumulation assays, the presence 
of PIA may significantly mask the contribution of Aap 88 which can in part justify the 
lower biofilm production and proliferation of PT12006 and PT12020 isolates. 
Together, those findings pointed out that the expression of the icaA gene is still the 
major contributor to the biofilm growth at larger-scales in in vitro assays. 
Interestingly, a dose-dependent effect on bhp expression and subsequent biofilm 
accumulation was not detected, while in aap a variable effect was found. Hennig 
and colleagues 82 reported that in contrast to bhp expression level, the expression 
of aap was upregulated in an icaC::IS256 but biofilm-positive mutant, and thus 
considered responsible for the biofilm formation. In fact, this finding might explain 
the biofilm phenotype observed in the PT12015 isolate (aap+bhp+). Despite the 28-
fold increase in the expression of bhp, this clinical isolate demonstrated a lesser 
extent in biofilm proliferation which could be therefore associated to the 
insignificant lower increase in expression of aap at 54 h (less that 1-fold). 
Moreover, the clinical PT11016 (icaA+bhp+) and the commensal SECOM004A 
(icaA+aap+) and SECOM049A (icaA+) isolates reveal lower levels of icaA 
transcription and biofilm biomass when compared to the other members of the 
group. In addition, NaIO4 had no or little effect on biofilm disruption, further 
suggesting a minor role of polysaccharides in the biofilm formation by these 
isolates. As PT11016 was recovered from a patient with an infected implanted 
device, it remains a possibility that more pronounced levels of icaA expression 
may occur in vivo than in the used in vitro conditions. Additionally, the levels of 
icaA expression could also be modulated by icaADBC inactivation either due to 
the insertion/excision of IS256 or IS257 elements in icaADBC genes 316, 317 or by 
the action of the icaR repressor 70. Similar results were therefore observed by 
Chokr et. al. 81 and Cafiso et. al. 318. Besides genetic modifications, several studies 
had established that the expression of icaADBC appears to be highly variable 
among clinical isolates 72, 319, 320 and the biofilm formation is a result of several 
stimuli 81, 321. 
By CLSM analysis we could observe that the structures of the biofilm matrix of 
icaA+ and icaA- are quite distinct. The structural morphology of the matrix formed 
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by protein-dependent biofilms is indeed less complex than in PIA-dependent 
biofilms, as reported before 290, 322. Through this work, no phenotypic or genotypic 
differences were observed among clinical and commensal S. epidermidis isolates, 
suggesting that both had similar capacity to develop biofilms in vitro overtime, as 
previously reported by others 295, 323-325. This observation can be supported by the 
analysis of the phylogenic tree as it provides some indication of the phylogenetic 
relationships between the studied clinical and commensal isolates. As observed, 
some isolates with different origins appears to be closely related although 
phenotypically and genotypically distinct from each other (e.g. PT12003, PT12004 
and SECOM004A). Additionally, both types of isolates demonstrated similar 
biofilm structure by CLSM.  
Collectively, our results showed that icaA gene is highly correlated to the biofilm 
lifestyle and revealed that the highly complex biofilm structure (bacteria and 
matrix) is much more diversified among S. epidermidis clinical isolates than 
previously described in the so called, “reference” strains. While we’ve confirmed 
that aap plays an important role in PIA-independent biofilms, only S. epidermidis 
isolates harboring the ica gene demonstrated the ability to develop thicker biofilms 
with a more complex 3D biofilm organization. Importantly, we were not able to 
significantly associate bhp expression to biofilm formation, in opposition to studies 
performed in S. aureus strains 89, 326. Nevertheless, other studies point out that 
isolates of S. epidermidis do not necessarily have the same response to in vitro 
and in vivo conditions 327 and therefore further in vivo research should be 
conducted on those isolates. 
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CHAPTER 5 
 
 
 
 
FINAL NOTES AND FUTURE PERSPECTIVES 
This chapter concludes this thesis and suggests future work. 
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5.1 Concluding remarks 
The incidence of HAIs caused by S. epidermidis has been on the rise due to the 
increased use of medical implant devices 328, 329. The pathogenesis of these 
infections relies on bacteria adherence to the biomaterial and subsequent 
accumulation, and production of large amounts of polysaccharides, proteins and 
other extracellular substances 33, 330. The bacteria within the formed biofilm 
structure are protected against the host phagocytes 202, 206 and are less effectively 
cleared by antibiotic treatment, if at all 278, 331. Thereby, removal of infected 
implants is a necessary solution, which highly increases the costs of medical care 
6, 328. Since it is highly likely that implants will be increasingly used as a means to 
treat or manage a variety of medical conditions, it is therefore essential to develop 
improved strategies that could limit the risk of colonization of those implants and to 
effectively combat infections when they occur. The development of preventive 
strategies will, in part, require a more complete understanding of bacterial factors 
involved in the biofilm lifecycle. In this context, this thesis was focused on the 
study of S. epidermidis biofilm cell accumulation and maturation with a particular 
emphasis on the understanding of how specific biofilm-mediating genes contribute 
to those stages of S. epidermidis biofilm development.  
Throughout this thesis, the genotype-to-phenotype relationship of Portuguese S. 
epidermidis isolates was addressed, with particular attention to the ica operon, aap 
and bhp - three main biofilm-related genes involved in biofilm formation. Chapter 2 
described the troubleshooting performed with two key techniques used to quantify 
biofilm cells throughout this work. Although widely used, both techniques were not 
yet properly optimized to use with older S. epidermidis biofilms, composed of 
highly aggregated cells. The achievements described in chapter 2 contributed to a 
more accurate quantification of biofilms at older development stages. In chapter 3, 
a local epidemiologic study was described which included the phenotypic and 
molecular features of 86 Portuguese S. epidermidis clinical isolates and their 
association to patient-reported outcomes. To the best of our knowledge this was 
the first study addressing the problematic of S. epidermidis biofilm-related 
infections in Portugal. Although limited by the number of used isolates, our data 
provided evidence that high rates of antimicrobial tolerance are indeed related to 
higher consumption of antibiotics inside healthcare institutions. The results 
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presented in chapter 4 describe the main objective of this thesis, i.e. to understand 
how ica, aap or bhp may contribute to biofilm maturation in bacterial isolates. A 
selection of previously characterized commensal isolates was also included in this 
study, in order to determine if the reported findings in clinical isolates were also 
valid for commensal isolates. Ours findings highlighted that icaA was the most 
important factor contributing to the formation of strong biofilms by S. epidermidis 
isolates. Additionally, no differences were found between clinical and commensal 
isolates, a result that reinforces the concept that S. epidermidis is an accidental 
pathogen 28, suggesting that S. epidermidis isolates found as part of the normal 
skin flora have the potential to cause disease. 
 
 
5.2 Future perspectives 
The results presented throughout the different chapters of this thesis, provided 
further insights on the S. epidermidis fitness while exploring the contributions of 
icaA, aap or bhp biofilm-mediating genes in biofilm accumulation and maturation.  
A major limitation of these findings is related to the fact that, biofilm growth was 
characterized using conventional in vitro approaches. However, to effectively treat 
and prevent biofilm-related infections, it is a priority to understand how bacterial 
biofilms are established and progress within the human body. In fact, it remains 
debatable whether in vitro-formed biofilms actually resemble biofilms formed in 
vivo eventually causing of S. epidermidis persistent and recalcitrant infections. In 
line with this statement, future research should be performed with in vitro flow cell 
systems or in representative animal models (such as, mice 332, 333, rabbits 334 or 
guinea pigs 335), to more accurately simulate in vivo human conditions. Flow cell 
chambers would be a useful tool for an increased knowledge about the biofilm 
dynamics within the human body, while animal models would better mimic the 
dynamic interaction between host-, bacterial-, and environmental factors during S. 
epidermidis colonization. However, in vivo assays are quite expensive and limited 
by ethical issues implying that experimental works need to be strategically 
conducted. Therefore, an important step, previous to in vivo studies, could be the 
inclusion of ex vivo approaches that mainly consist in improved in vitro assays 
where the liquid broth is replaced with human blood 336, 337.  
87 
 
Finally, all models associated to high-throughput “omics” technologies would 
provide a global picture of gene expression and protein synthesis, and thus a more 
comprehensive understanding of the pathogenesis of S. epidermidis and of its 
behavior within the human body, which is in fact, the ultimate goal. 
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